Go back

Mushrooms for the Mind & Immune System | Paul Stamets

2h 28m 56s

Mushrooms for the Mind & Immune System | Paul Stamets

In this Huberman Lab Podcast episode, host Andrew Huberman speaks with mycologist Paul Stamets about fungi, immunity, and psilocybin. Stamets opens with a stark warning: H5N1 bird flu has now jumped to 90 mammal species, and its 40–50% human fatality rate could make COVID look minor. He argues that the solution lies in "natural intelligence"—upregulating innate immunity using fungi that have evolved sophisticated defenses against bacteria and viruses over a billion years. Stamets explains that fungi and animals share a common ancestor, and that mycelial networks create vast microbiomes that underpin ecosystems and host defense. Mushrooms act as miniature pharmaceutical factories, and his company, Host Defense, funded research showing that Agarikon and Turkey Tail mycelium grown on rice produced striking results: in double-blind, placebo-controlled trials, the combination reduced vaccine adverse reactions and tripled antibody reservoirs against COVID, while shortening symptom duration by roughly five days in sick patients. The conversation also covers psilocybin, including clinical evidence for treatment-resistant depression, OCD, and addiction, the importance of set, setting, and therapeutic support, and the need for screening people with psychosis risk. Stamets closes by framing biodiversity as biosecurity, urging investment in natural products to prepare for future pandemics.

Transcription

24554 Words, 141966 Characters

English
Speaker 1I don't want to be an alarmist, but COVID is not the last pandemic. In Washington state right now, two dairy farms are in quarantine because of H5N1, bird flu. Bird flu has jumped to 90 mammal species, 90. And the fatality rate of H5N1, if it hits humans, is about 40 to 50%. That's going to make COVID look like a minor viral pandemic. And this is something that we should all be concerned about. So this is why I believe in natural intelligence, upregulating natural immunity, because your sophisticated immune system has the wisdom to be able to create the antibodies to protect the host, the system, you, and you are a natural product. Are you not? And natural products being used by each other is the lesson of evolution.
Speaker 2Welcome to the Huberman Lab Podcast, where we discuss science and science-based tools for everyday life. I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guest today is Paul Stamets. Paul Stamets is a mycologist, which means he studies fungi such as mushrooms and their applications for improving health and cognition. He is considered by many to be the father of modern applied mycology for studying and championing the use of specific fungi for improving immune function, cognition, tissue healing, and remodeling, including the brain, meaning brain plasticity, and learning. Today's discussion starts with how to use mushrooms and other fungi to bolster your immune system. And it makes sense that you could use mushrooms to do so, because they themselves have natural defense mechanisms against bacteria and viruses. We discuss the mechanisms by which that works, and the particular mushrooms and other fungi that may work best for improving human immune system function and why. I want to point out that I have absolutely no financial relationship to Paul's company, Host Defense. But during our conversation, I did ask him about the benefits of using mushrooms and other fungi to bolster your immune system. I asked him about specific mushroom strains and dosages and sources because I'm curious about these things and their possible applications for myself. And I know many listeners and viewers of this podcast will be as well. We also talk extensively about the use of psilocybin, the data on micro dosing, as well as larger dosing of psilocybin for mental health, OCD, anxiety, and what the clinical studies are really showing. And I want to emphasize that, of course, we cover both the established benefits as well as what's unknown and, of course, the risks. And we discussed the use of non psychedelic drugs. I want to emphasize that, of course, we cover both the established benefits as well as what's unknown and, of course, the risks. And we discussed the use of non psychedelic mushrooms for increasing brain chemicals, such as brain derived nootrophic factor, which is one of the many key components of brain plasticity or learning. I have to say, I truly enjoyed this conversation with Paul Stamets. He is a very unique biologist. He's been focusing on an area of science that for many years was not considered fringe, but it had not yet been embraced by modern medicine. And now that modern medicine has started to embrace things like psychedelic mushrooms, et cetera, he, in his very generous spirit, has embraced that. And I want to emphasize that, of course, we cover both the established benefits and the risks. And so today you're going to learn about what's really happening in this incredible area of biology and medicine. And his incredibly benevolent spirit comes through clearly. Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford. It is, however, part of my desire and effort to bring zero cost to consumer information about science and science related tools to the general public. In keeping with that theme, today's episode does include sponsors. And now for my conversation with Paul Stamets. Paul Stamets, welcome. Good to be here, Andrew. Very excited to have you here. You're the fungi man. And you know a ton about medicine, plants, immunity, how fungi impact cognition. I have so much I want to ask you.
Speaker 1Well, I would correct you on that. I know very little. And it's a classic example of when experts study a subject, they realize how much they didn't know and how much there is to know. So this is like one of my favorite books was The Crack in the Cosmic Egg. By Joseph Pierce, I think. And it's when you study a subject so in-depth, you have intuitive realizations. But you have this deep appreciation for the enormity of your ignorance. And that's truly the bottom of my emails. You may have seen the greatest achievement of science this century, the acknowledgement of our ignorance. And I live and walk that because I'm still a boy scientist just excited about life.
Speaker 2All right. Well, your humility is appreciated. But among humans, you have vast knowledge of. You have vast knowledge of these things that we call fungi. I think we can both live with that. Okay. Okay. Fair. Let's talk about fungi and how they impact the immune system. But if you could start us off with a little bit of basic biology about what fungi are and perhaps the variety of them. And just to frame how they would impact our immune system.
Speaker 1Well, that's a really good starting point. And I'd like to kind of go back. We shared a common super kingdom called a paisla. And the paislaconta were protists, you know, single-celled eukaryotes. And as they differentiated, there was the holozoa and the holomycota. That actually is the branch that led to mycota means fungi and holozoa means animals. And so the mycelium went the path of the fungi went the path when they became multicellular. It's called multicellularity. And the multicellularity. The multicellularity allowed the fungi to absorb and digest its nutrients externally. The path that led to animals from the protists and they became multicellular is we started encapsulating our nutrients. And then basically like a stomach. And we started digesting our nutrients internally. So this elaborated about a billion, a billion and a half years ago. I mean, in the context of the cosmos, that's not, that's like yesterday. A lot of yesterdays. But with fungi. So what's really exciting to me, and that's so important, I think people understand, is the complexity of these fungal networks. There can be in a single cubic inch of soil, one to eight miles enriched for soil of mycelial networks. There can be more than a million species of bacteria, you know, and more than a billion organisms that are co-inhabiting in this latticework of mycelium, which is a membrane. But it sets up a microbiome. And what it does is we know about fungi produce antibiotics, penicillin, et cetera. It staves off pathogenic bacteria. We share in common many of the pathogens that afflict fungi afflict us. E. coli, staph, you know, clostridium, et cetera. So what the mycelium was able to do is to create the basis of what we enjoy now as our food chain. And it's the biodiversity of these fungal networks setting up microcosms of enormous complexity. I just had an interesting question. I was having a conversation with an AI expert. When you think about the crosstalking between the receptors, when you have more than a mile of mycelium, more than a million species of bacteria, prebiotics setting up alliances with favorable bacteria, who then creates a quorum to push back against pathogenic bacteria. So it sets up an ecosystem of sustainability and cooperation. And that sort of bilateral, you know, communications between all these organisms. And then you start to think about the microbiome. And then you start thinking about the complexity of the crosstalk of the receptors, of all these organisms that come into agreement and alliance that we're going to create an ecosystem as we give rise to plants and animals that keep the, that give rise to forests and food chains that create the detritus that then feeds all these organisms. They have a self-interest in their mutual survival. So when you think about the complexity of the microbiome being set up by these fungal networks that give rise to the ecosystems that we enjoy. It's just. It's phenomenal. So the AI expert, I just had a conversation with the extra yesterday. This guy's an absolute genius. And he told me something I didn't know because I would have been advocating natural intelligence, not artificial intelligence, natural intelligence, because of the complexity of the ecosystems that we're just beginning to understand how deep this intelligence is in nature. And when he told me something I did not know, and I don't know if you've heard of this at all, but we have come up to a data wall where 99% of. Discoverable data in the human experience has already been discovered by AI. And then now there's a data deficit, where they go next. And he told me that some of the biggest minds in AI, they've identified exactly what I'm talking about, natural intelligence. We need to tap into the intelligence of nature because of the complexity of this cross-talking of all these organisms and the biodiversity microscopically that leads to us as macro organisms, 90% bacteria. You know, it's that this is a community of cooperating individuals, and they're across immunity and protection. And they have in common the healthy ecosystems that protect their own progeny and us. So now we have to be really responsible citizens taking care of the ecosystem. And I think this is very exciting. To me, this is opening up doors to discovery that just is heretofore unimaginable. But just because we don't know the mechanisms of action doesn't mean that it's not true. And that's so much of my life. We can demonstrate healthy ecosystems. Do we know how they operate? No. We have a sense, yes. But we know we make the investment in healthy ecosystems, and our bodies are ecosystems. And we are semi-permeable membranes, so there's a constant cross-molecular communication from the ecosystems in which we live to our internal ecosystems. And this multifaceted communication pathway is something that I think is really where AI can help us. And so I think natural intelligence will always succeed artificial intelligence.
Speaker 2I love it. And we're veering towards immunity. I just want to make sure that I understand something that you said earlier in the context of immunity, that these fungi, which are vast, have to combat bacteria. So they have mechanisms within them that allow them to do that. And I believe that's what's going to take us toward the idea that we can use, we can leverage those mechanisms to combat bacteria in us and viruses and other things. Before we continue down the path toward immunity, I have a question about the physical architecture of these fungi. I have two pictures in my mind. I'm sure they're incomplete. One picture is a flat fungi that grow out on things and maybe dive in between rocks and maybe grab onto the skin of animals and humans and live there under nails or who knows. That's the one picture I've got in between toes. And then I also imagine mushrooms growing out of the ground with a little stalk. And I'm guessing there's probably a third category of airborne fungi. What other categories are there? And if you would, I'm also curious about if we were to just look a mile above earth, down to the earth's surface, and then deep to the earth's surface and into the oceans, where would we find fungi? Like where there's concrete outside, are they running underneath the sidewalk? Fungi munch rocks, they munch concrete.
Speaker 1In fact, it's well known by road builders to get down the mineral earth because if there's any organic debris, then shaggy mane mushrooms are known to break through asphalt. You can crush a shaggy mane mushroom with your hand and yet it's got this Herculean force being able to break asphalt and concrete. But your question is very apropos and a big surprise to even most of us mycologists. There's marine mycology and now the oceanic depth of mycelium is just astonishing. More than a mile and a half down, they've done cork borers and they found all these fungi. The biggest reservoirs of fungi now in the earth, we think. In the oceans. And that's just the marine mycology, oceanic mycology, it's just being discovered. So realize that mushrooms are like the tip of the proverbial iceberg. There's mycelium everywhere, but mushrooms are made of mycelium. They are aggregates of mycelium. But mushrooms don't have a good immune system. They rot very quickly. Everyone knows that, you've got to eat mushrooms right away. But the mycelium is the immune system of the mushroom life cycle. And it's the mycelium that we are rotting. And it's the mycelium that we are really diving into that I think will have a paradigm shift in helping immunity of us macro organisms interfacing with the immunological wisdom of these mycelial networks. And that's what I'm super excited about because our ancestors over literally millions of years, I was like, it's going into the, like an encyclopedic library of fungal candidates. And through trial and error, oftentimes errors would end up killing you. But we were able now to select about 200 species of, we think about two to 4 million species that are out there that from trial and error of our ancestors, we know that they are compatible with our digestion, not known then as a microbiome. So we've been able to select out species whose molecular architecture and think about mushroom species of being miniature pharmaceutical factories. There's hundreds or thousands of novel molecules being expressed by fungi that are not occurring elsewhere in other life forms. And so our ancestors selected out these different species in libraries. And we now from this library of knowledge, we've really narrowed it down. There's probably more than 200, but there's 200 species that we have great high confidence. They're compatible with our microbiome, but more importantly is the mycelial networks are exponentially more powerful, 10 to a hundred times more genes are being expressed by mycelium. And of course that makes sense. Mushrooms are designed to be eaten. They attract insects and microvores, animals to eat it. So they're perishable. They want their spores to spread. So they want to be attracting insects, you know, and animals that can spread their spores. But just, I talked about the complexity in the, in the soil with all these organisms that are dancing on this matrix of mycelium. Think about the immune networks that have to be in place in order for the mycelium to generate a mushroom. So it's like mushrooms are the portal into this vast internet-like design system of, of the mycelium. And that's the immunological wisdom of nature. And this is what I'm so excited about. This is why I'm a, I'm a applied mycologist. There's lots of mycologists in the world, but I have focused, ever since I was 14 years of age into what can I do with fungi? And I first found mushrooms. And that was my portal into this vast mycelial intelligence upon which we walk. And now we're just, it's revolutionary. It's going to be paradigm shifting for medicine.
Speaker 2I'd like to take a quick break and acknowledge our sponsor, 8sleep. 8sleep makes smart mattress covers with cooling, heating, and sleep tracking capacity. 8sleep just launched the Pod 6, which is their most advanced sleep system yet. The Pod 6 is half the size of their previous models. It's 20% faster with its cooling and heating, and it has 10 times as many sensors for tracking your sleep. The reason why 8sleep is so effective at improving your sleep quality and duration is because it helps control your core body temperature. That makes sense because in order to fall and stay deeply asleep, your core body temperature has to drop by about one to three degrees. And to wake up feeling completely refreshed and energized, you actually want your body temperature to be increasing in the final hours of your sleep. 8sleep automatically regulates the temperature of your bed throughout the night. I've been sleeping on an 8sleep mattress cover for nearly, six years now. And with each new iteration of 8sleep, it gets better and better at figuring out what my body needs across the night in order to get the best possible night's sleep. If you would like to try 8sleep, you can now get the Pod 6 for the lowest price of the year. Go to 8sleep.com slash Huberman to get up to $400 off the new Pod 6 now through November 30th as part of 8sleep's Black Friday offer. Again, that's 8sleep.com slash Huberman to get up to $400 off. Today's episode is also brought to us by Our Place. Our Place makes my favorite pots, pans, and other cookware. Surprisingly, toxic compounds such as PFASs or forever chemicals are still found in 80% of nonstick pans, as well as utensils, appliances, and countless other kitchen products. As I've discussed before on this podcast, these PFASs or forever chemicals like Teflon have been linked to major health issues such as hormone disruption, gut microbiome disruption, fertility issues, and many other health problems. So it's essential to try to avoid them. That's why I'm a huge fan of Our Place. Our Place products are made with the highest quality materials and are all PFAS and toxin-free. I particularly love their Titanium Always Pan Pro. It's the first nonstick pan made with zero chemicals and zero coating. Instead, it uses pure titanium. I cook eggs in my Titanium Always Pan Pro almost every morning. The design allows for the eggs to cook perfectly without sticking to the pan. Right now, Our Place is having its biggest sale of the year. You can save up to $45 percent site-wide now through November 30th. Go to fromourplace.com slash Huberman and use the code Huberman at checkout. Again, that's fromourplace.com slash Huberman to save up to 45 percent site-wide. I love thinking about the fungi as pharmacies, and it makes very good sense the way you couch it in the ecological context. They have to battle things, but they also have to do things that aren't about protecting themselves and killing things, but just working in benevolent symbiosis with the stuff around them. Like, oh, you can grow to here, and I'll grow to here, and we'll share in nutrients, and we'll exchange maybe even immune function so that we can both continue to thrive. I can't help but asking, you were 14 when you first sparked, something sparked an obsession in fungi in you. Do you mind sharing what that was? It's my dear brother, John,
Speaker 1who's unfortunately passed. We grew up in a small town in Ohio, we came from an industrial family, but we had a fully equipped laboratory in the basement. My brother, John, was into chemistry, and my father served on the U.S. aircraft carrier, the Intrepid, and we got the Intrepid main radio for the whole aircraft carrier. So I love my older brother, John, he's, you know, six years older than me. He was going off to Yale, Yale University, and he would never let me do any experiments. He was a serious scientist. I wanted to blow up things, right? But he would park me in the corner, and I could listen to coded messages behind the iron curtain. So I strung a 200-foot wire with glass insulators and long-wave radio transmissions, and I was just in love with him. You know, he was my mentor by far, became my tripping buddy later on. But John went down to Mexico and Colombia and came back with his extraordinary stories of taking psilocybin mushrooms. And so he really sparked my interest. And he basically one time had told me, he says, Paul, I don't have time to get into this, but this is a really interesting area. And of course, I thought, okay, thank you, John. And so he stimulated my interest in fungi in general. And so I looked for psilocybin mushrooms for years and years. I couldn't find them. I stumbled into chanterelles and porcinis and, you know, shaggy mains and bluets. And so I went, well, I'm looking for psilocybin mushrooms, found all these edibles, what are they? And, Anyone who has not experienced The joy of the eureka of discovering a multicolored, beautiful mushroom by just luck or happenstance. It's just this amazing experience that brings you out into the woods with your family and children. It's multigenerational. Families have secret mushroom patches they pass down to the generations, but it builds a bridge multigenerationally. And so John also was into edible mushrooms, but I knew a lot more about mushrooms than he did. And so my mentor became my student. And so there was a great joy in my life just to be able to share this wisdom I was accumulating. But my brother, John, I'm so sad that he'd be the best podcast interviewer ever because he was so smart. He unfortunately died from cardiac arrest. So that's why I do pushups every day.
Speaker 2We'll talk about your pushup regimen. It is quite regimented. And I'm sorry for his passing, that your love for him and appreciation for him comes through in real form. I feel blessed. And as a younger brother, you also got to be the teacher, which as a younger sibling, I know the deep joy in being both the student and the teacher in the sibling order. So how long ago was it that at least it's documented that humans first started eating mushrooms of any kind? Do we have any sense of when they started? Dabbling? Because it can be a risky endeavor, too. It's going to be a risky endeavor.
Speaker 1But realize that most primates eat grub, fly larvae, maggots. Flies are attracted to mushrooms. They lay eggs. Maggots grow. So because there's 21 primates or 20, maybe 22, including humans, that eat mushrooms. There's a monkey in Bolivia that consumes more than 10, 15 percent of its body weight per year. They're eating mushrooms. So the primate to mushroom connection through grubs, you know, is very strong. This goes into the bizarre and the edgy stuff with Terence McKenna and stuff. But it really is true. Starvation is a great motivator for finding food. And you see these big, bodacious, soft mushrooms that have grub in them. You would eat the grub and the mushrooms. And you come to learn that, hey, some of these mushrooms. Some of these mushrooms are actually quite delicious and nutritious. So how far does it go back? I think it goes back immemorial. It goes back to our very primate beginnings. And the fact that we have more than 20 primates today that are known to eat mushrooms and know the difference between poisonous and edible mushrooms. Think about that. You know, they may not have the language skills and they don't have field guides, but they have generational knowledge of how to select out of the forest the edible ones and avoid the poisonous ones. So I don't think you can untangle. The evolution of primates with their use of mushrooms in general. And, of course, it's a Russian roulette. If you're not careful, you choose the wrong species and you die. Well, isn't that true how we found out about what frogs are edible and how plants are edible? So mushrooms are not unique in that sense. Humans love to experiment. And I think starvation and hunger is a great motivator
Speaker 2for exploration of new foods. I know we're going to get to immunity soon, but I have to ask, in thinking about primate evolution, and we, of course, are old world primates, is there a world where our primate ancestors consuming mushrooms thereby consumed molecules that impacted the genome of developing fetal primates? In other words, is some aspect of brain expansion and evolution across primates, can we link it back to molecules that are found in mushrooms? I mean, we know that protein consumption and fat consumption during pregnancy, greatly enhances brain size and weight, brain weight in offspring. We know that both directions, both if it's, if, you know, primates are deprived of those, but as well as like more omega-3s, more protein, it seems to lead to, in general, healthier, larger brain offspring.
Speaker 1It's a very, very plausible and well-thought question. And my answer is, I don't know. When I don't know something, I mean, I'm interested in this subject, but I don't have any knowledge. I mean, obviously. Nutrition is helpful for the human health and the healthier a mother is, the better she can carry a child to birth. So, that's obviously logical, but you're asking questions that I don't have a direct knowledge or answer for. And I want to be careful what I say.
Speaker 2No, I appreciate it. Yeah, I have this fascination with the idea that because of the enhanced sense of smell that females experience during pregnancy, that maybe they were able to detect both poisons to avoid, but also things, that could potentially impact the short- and long-term development of the brain.
Speaker 1So, anyway. Well, the danger here is that some of the most deadly poisonous mushrooms in the world are delicious, but it's your last meal.
Speaker 2Okay, that's the best warning for why not to go out and pick a mushroom and eat it without really getting educated first that I've ever heard. Okay, so immune system. I think most everybody nowadays understands that we have this thing called an immune system that's there to recognize self versus other, to destroy stuff that is of other, not of us, that is potentially going to harm us. How is it that fungi help that system thrive? And I'm interested in how fungi might do that indirectly by supporting the cells and the sort of robustness of the immune system, as well as ways in which I have this feeling you're going to tell us that fungi within us can actually just do their thing and combat bad stuff, not even necessarily through a. through our immune system, just through their immune system.
Speaker 1It's a classic example of more than one thing can be true, but more than a dozen things can be true. And this is the entourage synergism. What I like to trace back to my story about how I got involved with viral research and pandemics, because I think it's illustrative. In June of 2001, I published an article in a journal called Herbalgram, the American Bee. And I was part of the American Botanical Council. And what happened was in the 1970s, Dr. Frank Parano from the University of Washington Medical School, I met him at a conference. And he said, Paul, I'm a virologist. I found some antiviral properties in mushrooms. Can you get me the gypsy mushroom? It was called Varizitis caperata, Cortinarius caperatus now. It's a mycorrhizal mushroom. It grows in the forest. And most mycorrhizal mushrooms, we can't grow. So it has to be collected. It can't be grown. So I was a young mycologist. And I met this great medical doctor. And so back in the day, when Federal Express first started, I shipped him like 20 pounds of gypsy mushrooms. He ended up isolating a novel glycoprotein called RC-183, highly active against herpes viruses. So I thought to myself, well, great, Frank, you found these antiviral properties in the mushrooms. I'm going to survey the scientific literature. So I did a deep dive. And I published a one-page article with all the scientific research. I could find on the antiviral properties of mushrooms. I published that in June 2001. 9/11 occurred. A physician involved in the project BioDefense, BioShield, saw my article, reached out to me and said, listen, we're really concerned about weaponizable viruses. Smallpox in particular, flu, et cetera. There's a program. And we're doing a wide net. We need to potentiate host defense against potential pathogens. So I had a laboratory. I have a small business. You know, it's Fungi Perfecti. We have a host defense product line. I created the business to do research. So I had amassed hundreds of cultures, you know, hundreds of species. So they gave me carte blanche. And I could just shotgun. So I sent them. They did 2,265 assays for free. And I shotgunned massive amounts of material. I had no idea. It was an opportunity of a lifetime. You know? So I gave them mushroom fruit body extracts, the mycelium that made those mushrooms, those extracts. And I got the research results back. And they were phenomenal. Especially against orthopoxys and against flu viruses. So when I got the research results, I got a lot of attention. I got more resources. I got virologists going, what is going on? And you could actually listen to National Public Radio, myself. The deputy director of the FDA and the head of the BioShield program. We're in the top 10 of more than 2 million samples surveyed. We're the only natural product. But the top 10 of super selectivity against weaponizable viruses. So that was great. And it localized into this old growth mushroom called agaricon. Now I described most mushrooms rot in a few days. That's true with oyster and shiitake and maitake mushrooms. But agaricon is one of the longest living mushrooms in the world. It grows for more than 100 years. It grows in the old growth forests. It's now on the red list of extinction in Europe. You can't pick it legally. We still have it in our old growth forests in Northern California, Washington, Oregon, British Columbia. And also Montana and a little bit in Northern Arizona. So in the 1980s, I had focused on agaricon because it was such a mesmerizing mushroom. It's the only species in its genus. And it's the only genus in its family. So it's the only species in its family. The two other species just recently entered into the landscape. But reishi mushrooms have 300 species. So here's this thing that we did full genetic analysis, which is published in G3, Genes, Genomes, and Genetics, the full genome sequencing of agaricon, first one in history. But this is a great story because I started digging the agaricon and diascorides first described it in the first materia emetica in 65 AD as Elixirium adlongum vitam, the elixir of long life. What a beautiful name. Yeah. So you have this elixir of long life, longevity mushroom. It's been used for thousands of years, grows in the old growth forest. And so I did a deep dive on this. And this is what our research comes to today because we did have a big pandemic. And in 2020, I was approached by a group of people who had seen my research that we had published. What can you do with COVID? And there was also an earthquake. And so we went, we proposed, and we bundled agaricon and turkey tail. It's the very same material that was going into our nutraceutical product line. We just bundled them together, agaricon and turkey tail. We published three papers on turkey tail. Now, the FDA, the first thing they said is we don't want to overstimulate the immune system. Most people die from a cytokine storm, from COVID, Ebola, flu viruses. People die from a cytokine storm, an overexpression of the immune system. Fortunately, we had a breast cancer clinical study in, I think, 2012. In 2019, we found that when you grow the mycelium on rice, separate from the mycelium, separate from the fruit body, it ferments the rice into a micro-fermented unique product. We published in the Journal of Inflammation Research that it stimulates interleukin-10 and interleukin-1-RA. As you know, anti-inflammatory cytokines. So, we could upregulate immunity, but we could suppress the overexpression of the immune system by having these anti-inflammatory cytokines. So, we passed the test with the FDA. They wanted to, we can't overstimulate the immune system. People will die quicker. And how do you know this is safe? Well, fortunately, we had all the safety data. I had the BioShield data, which I also had published on. So, we bundled these two things together. It's been an extraordinary story. It's been privately funded. Through the Krups Institute of Integrative Medicine at the University of California, San Diego, and UCLA Medical School. So, we have 140 patients in two studies. And we just published in BMC Immunology the results for vaccine enhancement. We published that one first because we have a natural product trying to mitigate, you know, COVID.
Speaker 2You can imagine the blowback we would get. Well, half the country would just want to take that. And perhaps the more traditionalists would, in my mind, would think, okay, they're trying to create a replacement for vaccines and would probably buckle.
Speaker 1We have to hit this wall of antipathy that conventional medical doctors and scientists have against natural products, even though the majority of medicines have their origins in natural products. But you have this thing of fractionation to one molecule versus the synergism of the complexity. We kept the complexity. We kept the complexity in place. And so, our double-blind placebo-controlled clinical studies showed enhancement of mRNA vaccines from Pfizer and Moderna. And the big result that we got was of the 10 symptoms that are associated with adverse reactions to vaccines. And I just got a vaccine against COVID eight days ago. And I take a Garakon on turkey tail. And I had no adverse effects. I couldn't even tell I got a vaccine.
Speaker 2I think it's because of the blunted inflammation.
Speaker 1What we showed in this study was a statistically significant reduction of adverse reactions to the vaccines, which is remarkable compared to the placebo, which was the rice. So, it's the mycelium on rice. This is an immunologically unique product. Very different and better than the mycelium. Very different and better than the mushroom fruit bodies. So, the real surprise on this, Gordon Sachs, Andrew Shuboff, Christine Hector, and other individuals who are part of this team, there's like 10 or 12 co-authors. There's like 10 or 12 co-authors on these papers. It's to their credit, they decided, since they banked the blood of these 90 participants, they decided six months later, let's have the patients come back and draw their blood. This was not my idea. This is the genius of our team who came up with this idea. They withdrew the blood. And it turns out statistically significant, those people who took a Garakon on turkey tail and had the vaccine had tripled the antibody reservoirs against COVID. Then those individuals who just got the vaccine. Not only did we reduce the adverse effects of vaccination, but we extended antibody immunity, and they only took it for four days. Think about the extension of innate immunity. And so, this really got our minds thinking, how is this working? And our hypothesis, again, we have the results. Mechanisms of action, we can debate that all day long. But we think what it's doing, it elevates immunity to a higher state of regularity. So, your endogenous immune system can customize antibodies specific to the pathogen. It's trying to protect the system, the host. And the advantage of vaccines and their vulnerability is their hyper-selectivity. So, you get vaccine evasion from the viruses because they're really good at target-specific, but then the viruses mutate. And then you have immunologically compromised people who are mutating all sorts of vaccine-resistant viral strains. This is why we have vaccines that are different every season, right? This is trying to navigate around the viruses and building up tolerance. We think we've been able to take this to a different level. So, we have a second study. That was of 90 people. Now, these phase one studies, people know about phase one studies. They're exploratory for safety. We prove safety. No AEs, adverse events. But 90 people is a significant phase one study. It's not like six or 12. Many people know. They do tests. You know, safety studies. So, we're really beyond, you know, the simple low population test. Then we went to 50 people who were recruited when they were sick. And do you want to be involved in a COVID clinical trial using mushroom, mycelium?
Speaker 2Just the mushroom, no vaccine.
Speaker 1Now, this is important because some people actually did get the vaccine, but they still got sick. So, we had three ways of slicing this pie. We got two slices of the pie where we show statistical significance. The third slice of the pie, we don't have enough people to be able to understand exactly what happened. But what we found, which is just very controversial, but the data speaks for itself. You know, this, again, the top 10 symptoms. Massive reduction. And the significance values are huge. There are three zeros, big F factors, high significance, high impact. Statistically, a significant reduction in headaches, muscle aches, and sneezing, coughing. Those last two, those are vectors of transmission. Inflammations, when your muscles hurt and you have a headache, sure, that's internal. But the fact that we're able to reduce significantly coughing and sneezing, that's significantly reduced the vector of droplet dispersal. So, that was amazing. When we look at the metric, and we have great statisticians in our study, how long was there a resolution of a reduction of 50% of the symptoms with people who were unvaccinated who took a Garakon on turkey tail? 5.1 days sooner than placebo. Those people were vaccinated. And they got a Garakon on turkey tail, 0.9 days. Tamiflu only reduces your disease symptom period by about one day. We were able to show statistically significant reduction five days earlier, comparatively. So, this is like, what is going on here? I think we put upregulated immunity, and we've been able to decouple reactogenicity to the vaccines with immunogenicity, upregulated immunity. As you know, inflammation and the immune stimulation, they go hand in hand. You get cut, you know, you get inflammation. The fact we're able to decouple these things, it's almost like an oxymoron in medicine. What is going on here? And this is, again, we can get into arguments and discussions about what's going on, but the proof of the fact is the patients, this is what they reported and saw. So, it was like aspirin. We didn't know how aspirin worked until the 1970s, but it was being used well before that. So, this is where we come into this new area of enhancing conventional medicines, which I. I believe in conventional medicines, but I think we need to elevate our ability of our immune system to be able to make conventional medicines work better. And if we can elevate community immunity to a higher state of readiness, then I think that helps not only the individual, but our communities.
Speaker 2I'd like to take a quick break to acknowledge our sponsor, AG1. Earlier this year, AG1 launched their newest formulation, AG1 Pro. AG1 Pro takes the clinically-backed AG1 formula, which is a blend of vitamins, minerals, probiotics, and adaptogens, and adds in three important new ingredients. creatine monohydrate for muscle strength and performance, calcium HMB for muscle recovery, and zinc carnosine for gut health. These are ingredients that I've been interested in, and in some cases taking already for a long time. So it's great to see them added to the existing AG1 formula. If you would like to try AG1 Pro, go to drinkag1.com slash Huberman to get a special offer. From now through the end of November, you can get 25% off your first subscription to AG1 Pro. Just go to drinkag1.com slash Huberman. Again, that's drinkag1.com slash Huberman. I'm going to attempt a brief summary to make sure I'm on board and the listeners are totally on board. It was very clear, but so by increasing the activity of the immune system, but simultaneously decreasing certain activities of our immune system, you were able to carve this narrow path whereby people had fewer symptoms and yet were able to combat the infection more effectively. You also mentioned that because there was some enhancement of immune function, it raises the question for me, is that because of some sort of hormetic effect? Like when we take something that is a quote unquote stressor, our immune system responds, and that actually can be beneficial. Like exercise, for instance, has many benefits, but among them, our ability to combat infection, as long as we don't over exercise and we sleep enough, et cetera, there's kind of an inflammation response to exercise. So it's kind of hormetic in that sense. So a skeptic, I'm not saying this is me, but I'll play the skeptic for a moment. I love skeptics. We'll say, okay, well, you're ingesting a little bit of poison and that little bit of poison is not sufficient to kill you at all, but it's creating an immune response that allows you to deal with other foreign invaders. Is there any idea for or against that based on these particular species of fungi or the mechanisms known? I realize that the outcomes are, as you pointed out, really, you know, you're not going to be able to do that. You're not going to be able to do that. I'm just trying to understand what might be going on here.
Speaker 1Yeah. Well, that's bringing us into the discussion of the implications of in vitro tests, you know, basically human cells in petri dishes versus real world, you know, individuals consuming this and what are the outcomes. It speaks to mechanisms of action. And what we also publish with lion's mane mushrooms and mushroom mycelium, as well as with a turkey tail and agarica. Yeah, that's a great point. And I think that's a good point. When LPS lipopolysaccharides, which are coming from endotoxins of a bacteria, it's used in thousands of papers, you stimulate inflammation with LPS. And what we found is the human cells digitally express genetic responses that show that under stressful conditions, it dampened the inflammation that would otherwise cause inflammation. And so, you know, I think that's a good point. Leprechaun mycelium with the PBMCs, with human blood cells in petri dishes that upregulate, downregulate. I mean, do you think about more than 500 genes are involved in the immune system? This, again, speaks to the entourage effect. And will we get better with this research? I think we will. And I'm happy that we now have 130 strains of agaricon in culture. It's one out of 100 times what we find in the immune system. We now have phenotypes. Think about the varieties of tomatoes, just like in the garden. We have different phenotypes. And the story of the discovery of penicillin goes to Mary Hunt's cantaloupe, penicillium chrysogenum. She found a moldy cantaloupe in Peoria, Illinois, and she brought it back to their research lab. And even though Alexander Fleming and his colleagues found penicillin, they couldn't industrialize it. Mary Hunt's cantaloupe, you know, produced 200 times more penicillin than anything else that had been seen. So it allowed for the industrialization of penicillin. Similarly, we're looking for super strains of agaricon. So we just received notification of a $2.6 million grant to go into our genomic library of agaricon to find super strains that are active against a variety of viruses. We already got lucky. And one of the articles that we just published, we had agaricon extract from the BioShield program in 2004 on a shelf in a glass gallon mason jar that sat there for 17 years. Then four years it got put into refrigeration. We pulled out that extract that was showing positive results in the BioShield program against pox viruses, herpes and flu viruses. We pulled out that extract. It's in 35.5% ethanol, so there's no beta-glucan. It's a supernatant. Beta-glucans precipitate for 25% alcohol. So nothing to do with beta-glucans. We retested it and it's massively active against COVID. And the cells that got plaque when exposed to the COVID virus, then the plaque is dead surface tissue and then the cells die and all these virulence get spewed out. The cells then healed within five days. And so 20-year-old extracts, shelf stability of this natural product is active against multiple viruses. This is like mind-boggling. And I'm so glad we saved the extracts because we have a shelf stability study. So that is in vitro. But now we have in vivo the clinical studies with humans. So here's a case of translational medicine. Now really penicillin was discovered because inhibiting, I think, staph bacteria in the petri dish as an accidental contaminant. And that's how we was discovered. So that's in vitro to in vivo translational medicine. Now we have beginning the bridge of this in vitro to in vivo to human clinical trials. Where is it going to go from here? Well, the potential by my colleagues who are speculating is totally hypothetical. What if we could enhance most vaccines by increasing immune readiness? What if we could enhance most anti-cancer drugs by elevating the immune system to a higher state of immune readiness? So these drugs for their target specificity can work better without having the deleterious inflammatory consequences of nonspecificity.
Speaker 2Well, I guarantee that half of the people listening are thinking, great, let's enhance the efficacy of these vaccines. And the other half are thinking, how can we reduce the side effects of the vaccines? Actually, it's probably more finely sliced than that. And then there's probably a third category. So maybe it's 30, 33, 33, 33 and some change that are, as we know, are very anti-vaccine. You know, in my role as a public health educator, science educator, you encounter all three. It sounds like these tools would be very useful in each and every case.
Speaker 1I absolutely agree.
Speaker 2There is now, I mean, we don't want to get into the politics of all of it, but these camps are pretty rigid. People rarely cross lines. But it sounds like everyone could, there's a benefit to each and every one of these bins. I want to really highlight something that you said earlier, and it echoes what a former guest on this podcast, someone I think very highly of, Chris McCurdy, who's a professor down in Florida. He's a professor in the Department of Health Studies, Kratom and other leaf products, as well as compounds in their natural whole form of the plant or leaf said, which is that most pharmaceuticals were bio-prospected from plants and other aspects of the natural world. And I think, I feel like that can't be said enough. You've said it today, and I'm grateful for that. Chris has said it. And I think because most people, when they think about the pills they get, the tablets they get from a prescription or over the counter, they know it's been synthesized in a lab, but I don't think they understand that those molecules were discovered in the natural world. It just doesn't really compute.
Speaker 1They don't want to miss school. They want to take the risk of not getting the vaccine and avoiding the virus. So think about 30% non-conformancy in taking a vaccine because of fear of adverse effects. This is why with Moderna and Pfizer, this is a force amplifier, right? This actually amplifies the efficacy and gets more people to take your vaccines. But vaccines, because of their hyper selectivity that I mentioned, and because of. The ability of these viruses to avoid the vaccine efficacy, it really means to me that we should think about this in a wholly new way. And what I have come to realize is the immune system is so much more complicated than what conventional medicine thinks. When you do bio-gatted fractionation, and we did it with agaricon, and I can tell you the active molecules that we found. And we did it with agaricon, and we did it with agaricon, and I can tell you the active molecules that we found. feronic acid. And then ferulic acid also. These are polyphenols, you know, they're ethanol-soluble, not that water-soluble. And the mycelium of agaricon has those three. When we tested those molecules individually, they didn't have the same effect. It was like, wow, we found active it's called biogated fractionation. You take a natural product, you have a highly polar versus a non-polar, you know, water being polar or hexane being non-polar. And you go down to basically a decision tree and you test each one. Is the potency against viruses increased or decreased? And then you elaborate this down to a single molecule. That's called biogated fractionation. That's where the majority of our medicines have come from, from that simple research. Now we have AI, so it accelerates it. So biogated fractionation, you can biofractionate into an activity. Because again, think about all the receptors that are crosstalking. And this is what I really believe. Our immune system is like a sophisticated computer of natural intelligence. And when you ingest something that it recognizes as being helpful for the whole system, then I think there's crosstalk between these receptors and the immunological landscape that's saying, okay, open up your receptors. This is going to be helpful. I know I'm waxing a little bit into the complexity and the entourage effect, but then nevertheless, we are seeing this to be true. And again, we argue about mechanisms of action and biogated fractionation, but this is why natural products have not an entourage effect. And through the theater and science of nature, we have so many different candidates we haven't explored. We only tested less than 0.1% of the fungal species that are out there. We will have, from the intelligence of nature, we will have some very powerful natural products that are still in our library of potential medicines that we haven't even explored yet. I think molecular medicine is fantastic. I'm not throwing it under the bus. I just think there is a bridge between these two that we can increase the homeostasis. From my point of view, health and disease is a multifactorial equation. We have coefficient multipliers on this side, the end of which is disease. So what can we do to have a force amplifier? And I think mushroom mycelium is a force amplifier on the left side of the equation to make the end result on the other side of the equation better for the individual.
Speaker 2Earlier, you were describing, this work on the immune system, I drew a little diagram for myself, which said natural products and then traditional medicine, and they're sort of interdigitated there. I really feel like you're operating, looking at the interface between those in a way that, to be direct, I don't know many people are. And you've mentioned many times the entourage effect. I mean, it seems intuitive to me, and I think it's starting to become intuitive to the public, especially in the wake of the pandemic, that first of all, no one's going to come along and give no government, no pharmacy, can give you the one thing, the one molecule that's going to solve all your problems in any domain, mental health, physical, it's just not going to happen. There are things that can help, certainly, but that cocktails of things that work and synergize are increasingly being looked at as beneficial. And the idea that we could, that one could, and you are, leveraging existing organisms that have already worked this out in order to enhance immunity, for instance, is really exciting. Could you share with us, for those interested, meaning me, I'm raising my hand, let's say I feel like I'm coming down with something, a cold, I'm getting that sort of innate immune response, I'm tickling the throat, this kind of thing, or I'm battling a cold or flu or COVID or something like that. What is this cocktail? Don't be bashful here. I want to try it next time I get sick, and I want to know when to take it and for how long, or is there something I should be taking continuously? I walk my talk,
Speaker 1and I created my business, Host Defense, in order to do research. And the research now is proving that our Host Defense products support immunity in healthy individuals. That's very clear. We have multiple, you know, peer-reviewed articles out. This narrative is picking up speed. And so, I've been on the sort of lecture circuit. I've been around thousands of people. I mean, just like you, I'm sure, you can't go through the airport without having selfies and people coming
Speaker 2up to you. You're known as the mushroom guy. I know that's not all you do, but.
Speaker 1So, what I do is I take Host Defense, Agaricon, and Turkey Tail. These are the very same materials that we supplied in the COVID clinical trials.
Speaker 2Agaricon and Turkey Tail. And Turkey Tail, Host Defense. These are mushrooms that grow in the wild near each other?
Speaker 1We cultivate them in our laboratories. We have FDA-inspected laboratories. We've had what's called no 483s, which is a pharmaceutical. A grade level laboratories for our extracts.
Speaker 2But in the wild, would these two grow near each other? I'm just curious.
Speaker 1They grow in the same forest, but we take tissue cultures from them, and then we bring them in the laboratory. We grow them in pure form. Mushrooms that grow for 100 years, you can imagine, Agaricon is subjected to air pollution, to algae, to bacteria, and Turkey Tail mushrooms also. Anyone's collected Turkey Tail mushrooms, they're a bracket mushroom. They're called Turkey Tail because they look like the feathers of a. of a turkey. They're multicolored. It's called Trematis versicolor. It means variable in color. When you look at Turkey Tail, it has algae, and it also sequesters nitrogen through agrobacteria. So, it's a polyculture. So, when you get a young Turkey Tail mushroom versus an old one, this is the problem with mushroom fruit bodies in general. They are parasitized by bacteria. They rot so quickly. They're contaminated from air pollution. I mean, one of the biggest concerns I have is mushrooms coming from China. And I had someone tell me that there's no pollution in China, and looked at me with a straight face. And I'm just like going, "You're batshit crazy, dude." But they're wedded to this concept that mushrooms from China are clean and pure. It's just contrary to my factual understanding and testimony. So, the in vitro grown propagated mycelium by itself, grown especially on grains, because epigenetically, we're seeing the mycelium fermenting the rice creates a unique product. It's like milk being added to lactobacillus and acidophilus. It creates yogurt, right? It's a fermented product. So, it's biotransformed. So, in our clinical trials, you use rice as the control. So, you know, rice is not a filler. It's a biotransformer, right? It changes the rice into this unique immunologically powerful product that does not overstimulate immunity. So, what I do is I take agaricon and turkey tail. So, I took this morning, four each of host defensive agaricon and turkey tail, and I've been exposed and sneezed upon. And I'm at the end of one study for myself, but this is my go-to thing, is I take agaricon and turkey tail. I take- And what dosages? I mean- I take four capsules-
Speaker 2Again, I want to be clear to those listening. Let me just, forgive me for interrupting, but like, we didn't come in here to like explicitly do a promotion. I just know that as people hear this information, some people will be very curious. They'll want to know what to do, right? And I, for one, hate being sick. I hate being sick. And I don't get sick very often. I tend to move through it pretty quickly if I'm doing most things right. But I would love to be sick less often. And I would love to move through whatever respiratory or whatever stuff more
Speaker 1quickly. I cannot make medical recommendations. I can tell you what I, am doing. And I'd advocate people follow the science. I populate a website with my team. I have six full-time researchers, four PhDs. You know, we've published like 65 articles amongst us in peer-reviewed literature. We curate a website called mushroomreferences.com. It's over a thousand references now, which has all the, as many of the peer-reviewed articles on mushroom mycelium, mushroom fruit bodies, has adverse reactions also, things that- have been reported to be bad concerning mushrooms, you know, of which there are several reports, you know, shiitake dermatitis. Some people get an allergic reaction to shiitake from even touching the mushrooms and touching their skin. They can have a dermatological adverse event. So yes, I sell a nutritional supplement product line. Why do I sell it? Because I wanted to do research. I couldn't get money for research. I applied to a, but I didn't get any money for research. I applied to a, 10 NIH grants. We got two of them approved. You're on pins and needles. The timelines are so long, but I can be an adventurous investigative researcher and I can dare to fail and not suffer lack of tenure. I own my own company. So I've used my company and my motivation was to do research. In order to do research, I needed money. So I created my intuition, a product line. And now we have the science that supports my intuition. So it's a deliverable. I really want to save lives. I mean, I don't need to make money. I'm okay. You know, I want, you know, what is your legacy? I want to be my legacy. I want to be, wow. He was on the edge. He was a, you know, an edge runner. He was way out there, but damn it. He was right on some of these things. Millions of lives have been saved as a result. That to me is the legacy I want to live. Hey, Galileo had the same, you know, it was opposed by the church. I just heard from the Vatican, a person was in the Vatican, the Vatican admitted, we were wrong about Galileo. Galileo, and now they're interested in life on other planets. This is what happens when you're including yourself. You push the envelope, but we need to have credible facts to support the arguments because hypotheses become theories, become actionable solutions. And that's why I'm in applied mycology. I want actionable solutions. So you asked me what I take personally. I take agaricon and turkey tail from host to fence. That's what I do.
Speaker 2Do you take it going into an infection and through it and through the other end, or is it a daily regimen for you?
Speaker 1Great question. Prophylactically, I up my regimen prior to public contact. My partner and I live on a remote island in British Columbia. We live surprisingly, extremely quiet life. And then we're thrown into the vortex of the public. And then we're- Before we go, then we start upregulating our immune system by taking agaricon and turkey tail. Also, I'm getting older. So I have an immune deficit that's increasing. So I want to upregulate my innate immunity. So that's really important for me. So I take it prior, several days prior, during the duration, and then I back down to more of a, you know, the therapeutic dose versus a you know, differences.
Speaker 2So- Well, first of all, thank you for sharing your deeper and larger motivations. Your sincerity comes through. Your commitment to these organisms and how they can be useful to humans and to the ecosystem that we live in also comes through with sincerity. It's not just me.
Speaker 1There's a bunch of other mycologists- There's your humility again. No, no. No, no. I appreciate it.
Speaker 2I'm just saying, true scientists always give us a proper attribution. So no, please, I realize that you're embedded in a context and an ecosystem of other scientists. I didn't mean to imply that you've done this all alone. I asked about the action rules because people will know. Some people will want to do this, right? You know, some people want to try, other people won't, and that's fine. I will say, just as a brief editorial on the scientific process, having had NIH grants and sat on NIH review boards for, you know, more than a decade and saw what that process is like, how it can serve and how it also has flaws. I think any scientists, NIH funded or not, will say that there are flaws in the system. I think having a good question, which always requires funding to do science, it's necessary, but not sufficient for good science. You need money to do science, is critical to evolving the scientific and therapeutic landscape. And as you pointed out, if you look historically, there's always been a established process. Actually, a wonderful book is a very dense book about Galen. It's called The Prince of Medicine, which talks about how medicine evolved and based on whether humans could do surgeries on other humans or not. Turns out gladiators, it was okay. They were already cut open by each other and you could dig in there and animals versus non-animal research. It's very interesting, its relationship to the church and on and on. Nowadays, I think because of the pandemic and because of the internet, I think there's deeper and larger appreciation for people taking a variety of approaches to exploring questions. You and your colleagues were early to this approach. And I just want to second that approach as somebody who also respects the traditional approach. So I just want to highlight that great science, it's going to be done many different ways and through many different channels.
Speaker 1Yeah. And we should be collaborative. My best supporters have been my skeptics and they've taken me to the map and I go, okay, where's the peer reviewed articles? Here they are. Where's the double-blind placebo clinical trials? Here they are. Next question. And they have to face whether they actually have a prejudice. They were demanding this before and now we've delivered it. Why are you in denial that natural products can be helpful for the immune system? Right. It becomes a point where there is a scientific bias. Now, most good scientists, you know, and this is why my best supporters have been my skeptics. And I'd love to give you a list of names, but there are notable scientists that want, you know, and the BioShield biodefense program, so many of my supporters in that program feel vindicated for supporting me now because they've seen the clinical studies. So this is something I wanted to mention, and I don't want to give away too much information, but I just want to give you a little bit of an overview of what I've been doing and how I've been doing it. And I want to give you a little bit of an overview of what I've been doing. COVID is not the last pandemic. Bird flu has jumped to 90 mammal species, 90, killing seals, sea lions, of course, all these birds you know about, but also killing marmots, all sorts of other mammals. The fact that it's jumped from birds and now 90 mammals is a warning bell. And the virologists that I know who are involved in bioweapons defense, and we just came out, what, three weeks ago, the heads of AI platforms saying the biggest threat to humanity's extinction is bioweapons being engineered by artificial intelligence. This is the inexpensive bioterrorist weapon, is to create a viral pandemic with specificity. So this is why I believe in natural intelligence, upregulating natural immunity, because your sophisticated immune system has the wisdom to be able to create the antibodies to protect the host, the system, you, because of this microbiome that we've come from with mycelium and this plurality of individuals who are unified to protect the system, you, and you are a natural product. Are you not? So it should be all hands on deck. We need to focus on this. I am so honored that a medical researcher at the University of California has awarded us $2.6 million to look at every strain of agaricana. We have 130 strains for hyperproducers. We want to find a Mary Hunt strain against H5N1, you know, like she found with against penicillium chrysogenum. So we have this library. And if there's anything that I can communicate, irrespective of me, irrespective of any ego, money, the investment in biodiversity is an investment in our biosecurity. These are rivets of an airplane. How many rivets will we lose where the system will then dismantle? Now we have factory farms, unprecedented transportation of individuals. One person on an airplane, like Ebola, they had to test 200 people that he was on an airplane and really sick and went to Kenya. And now they're, they're tracing. And the tracking of Ebola, because of the infrastructure, it's, it's gotten out of control. So we have so many potential viral pandemics. And the other thing that people may not understand is you can co-incubate multiple viruses and then you get horizontal gene transfer. And the bacteria that are also growing can become a platform for horizontal gene transfer. We are in an unprecedented times of population density, transportation, factory farming, and now AI, and batshit crazy terrorists who want to create Armageddon. So this is something that everyone needs to work together. And what I'm offering is a platform, a foundation to elevate conventional medicines to a higher state of efficacy. We have to prove it. But for instance, I published in Nature Science with my colleagues, reducing viruses and honeybees up to 14,000 times less viruses and honeybees in 10 days. And the deformed wing virus is a pandemic against beehives, Apis mellifera, the honeybee. My colleagues at Washington State University, some of my employees and other scientists from the USDA, Jay Evans, are all co-authors. He's a renowned virologist. He's never seen anything work so well. We were able to extract these polypore mushrooms in the sugar water. And we were able to give it to him. And in 10 days, it had like a 14,000 times reduction in the viral titers. The deformed wing virus, the wings become weak and they deformed and bees used to fly for seven to 10 days. Now they're flying for four. One bee pollinates 1,000 flowers a day. So you think about 4,000, 5,000 less almonds and cherries, apples. It's a threat to biosecurity. We are in a bee apocalypse right now. The worst die off of honeybees in the history of this area. And we met with the FDA and we've been trying to meet to get this approved. Number one, they don't want to hear about honeybees. Number two, they don't want to hear about honeybees. They want to hear about viruses. But I actually had an FDA regulator on Zoom look at me in the eye and say, okay, we want you to characterize all the constituents inside this natural product. And I said, may I say something? And she said, yes. And I said, you know, there's more than 200,000 constituents in this product. You want us to characterize every single one of them? And she literally couldn't say anything, like for 45 seconds. You take a pharmaceutical that's 99% pure, then the impurities are less than 1%. So that modality of thinking that you want to test all impurities. What's the act of constituent? This is where natural products face this huge barrier of regulators. You cannot get these products to market because a bureaucrat in Europe, they've outlawed the selling of mycelium because they say it's a novel food, but mushrooms are made of mycelium. So one regulator makes a decision that denies Europeans the ability of being able to buy agaricon or turkey tail mycelium for pandemic defense.
Speaker 2I'd like to take a quick break to acknowledge our sponsor JUV. JUV makes medical grade red light therapy devices. Now, if there's one thing that I've consistently emphasized on this podcast, it's the incredible benefits that light can have on our biology. Red and near infrared light can have profound effects on improving our cellular health, including mitochondrial function, which in turn can lead to faster muscle recovery, improved skin and wound healing, reduced pain and inflammation, and more. What sets JUV devices apart and why they're my preferred devices for long wavelength light application for health is because they incorporate the specific wavelengths of red, infrared, and near infrared light at the right intensities. And they're one of the only commercially available medical grade long wavelength light devices available. When I'm at home, I use the JUV full body panel in the morning. And when I'm traveling, I rely on a handheld JUV Go. If you would like to try JUV, go to juv.com slash Huberman, spelled J-O-O-V-V.com slash Huberman. Right now, JUV is running their biggest sale of the year. From now through November 30th, you can save up to $1,200 on select JUV devices during their Black Friday sale. Just go to J-O-O-V-V.com slash Huberman. It's interesting because there are some parallels within the realms of physical health and mental health tools that are purely behavioral. So I'm 51. You're about 20 years older than I am. I'm 71. All right, great. So you and I can remember a time where if somebody meditated or did what would now be called breath work or did yoga or lifted weights for that matter, that they were part of an extremely niche community that was either ridiculed, ignored, or just considered fringe. And there were probably additional reasons for that, like things that were within those communities that were at the time, like the sociopolitical environment made those like kind of more fringy, right? But now having the 80s, 90s, and early 2000s has tons of studies. And now, you know, even more studies on the benefits of resistance training, meditation, breath work, yoga, and now actually great work from Chufu Ma's lab at Harvard is showing that acupuncture and its specific arrangements of needle and pressure points can liberate certain molecules and, you know, mechanistic understanding. Now everyone goes, oh yeah, you know, like meditation can help make you more calm, make you more focused, etc. But not particularly. Not, but 10 years ago, that stuff was considered pretty wacky. And we know there are studies that can say, well, you know, this particular protein is upregulated in response to resistance training or breath work of this type. And, but the practices came first and the validation of those practices came later and many through NIH funded studies. So I point this out only because I think times are changing. I think the younger generation, you know, 35 and younger, they grew up in the context of people just doing this stuff. They themselves might not do it, but it's not considered as strange. So I feel like things are shifting toward the better.
Speaker 1Well, we're left coasters. We live on the West Coast. There's always resistance to change. And I am a blend of being a conservative and I'm socially liberal, but I'm also, I come up from a farming family of wheat growers. You know, we have thousands of acres of wheat in my family. I'm happy to inherit 200 acres, but talking to my relatives who are farmers, any potential change from the system is very dangerous. Their margins are so thin, they can't risk change. You know, let the scientists do that and then prove it. And then they give us a new deliverable that we are confident in. But it's just natural for a conservative scientist even to resist change. They have to worry about reputation, tenure, and failure. This segues into my psilocybin experience. When I first went to these academic conferences interested in psilocybin, two things happened. One, it was like I had, I was a leper. There was a force field. I'd walk into a crowd and there's a force field that would distance themselves. Here comes the hippie second off. Here comes the hippie interested in psilocybin. It was extraordinary. I refused to be an apologist for my interest in psilocybin. And now it's a revolution sweeping the planet. There's a revolution from the underground. 5% of Americans admitted they used psilocybin last year. Microdosing or macrodosing? Both. That's over 8
Speaker 2million, by my calculation, Americans. Do you think this is because of the studies on repeated use of psilocybin as beneficial for major depression? Yes. Yes. The clinical trials.
Speaker 1Clinical trials for people who are depressed, PTSD, all sorts of other. And then increasingly, there is evidence that psilocybin increases neuroplasticity, and creates new neural networks. And that's the area we have focused a lot of attention on. I'm with a research group, and we're very excited about what we're seeing. Other scientists are now also showing the same thing. The observational studies, and this is easily discoverable to anybody who wants to search the web for this, statistically significant association of a deduction of crime with a person who's done one dose of psilocybin, partner to partner. And now it's over 8 million, by my calculation, and it's over 2.5 million, by my calculation. That's a significant increase in the number of people who have used psilocybin in the past year. Two heroic doses of psilocybin, 90% of people addicted to tobacco compared to the nicotine patch one year later were not smoking. So you define heroic dose? Let me define it in several ways. For those of you who know what psilocybin commences, the golden tops, that's the most commonly cultivated psilocybin mushroom in the world, super easy to cultivate. That typically is over two and a half grams. Really, the hero's journey is around four to five grams. This is where, you know, I'm not going to go into too much detail about psilocybin, but I'm going to go into You have set and setting, and it's so important you have therapy afterwards. It's so important that people don't do it. Would you say before, during, and afterward? Preparatory is really important, so you don't have to understand what you're going to experience. There's a great nonprofit in Canada called Roots to Thrive. Dr. Pamela Crisco is one of the co-founders of it. They really have a lot of experience with end-of-life, permitted by the Canadian government, you know, on a case-by-case basis.
Speaker 2We should probably, before we continue, forgive me for interrupting, we should touch on, you know, legality, and we should touch on categories of humans for which there's, could be elevated risk. So, as far as I know, as far as I know, psilocybin has been decriminalized in the United States in a few places, but is still, I have to pronounce this very clearly, illegal to possess or sell. That's my understanding.
Speaker 1Absolutely. Very important. And you cross, you know, state lines, you're involved in interstate transportation of a Schedule I drug. Possession of it is federally illegal. Transportation across the country is illegal. So, you know, it's a very, very important thing. State lines is very federally illegal. So, Oregon and Colorado have decriminalized. I've spoken in front of two city councils in Washington state, and unanimity of the city councils to decriminalize the possession of psilocybin to the lowest priority of law enforcement. This is one of the few times that I'm going to say, lawyers, what a great idea you came up with. They made it less of a violation than a parking ticket. So, they decriminalized it, didn't legalize it. So, Olympia, Seattle, Mount Vernon, Port Townsend.
Speaker 2All the places with a lot of trees, Oregon, Colorado. What about categories of risk? So, my understanding of the literature is that people who have a genetic or let's just say familial or other predisposition to psychosis or bipolar disorder need to be- An abundance of caution. Very, very careful. This is very, very serious.
Speaker 1They need to be pre-screened. They need to, we need to have adults in the room on this. This is not a party drug. This is serious medicine. 80% of people typically have a positive experience. The Compass psilocybin studies are showing about 40%, 45% resolution of treatment-resistant depression or major depressive disorder. I don't remember which, but it's clearly a very powerful medicine. Doesn't it work for everyone? Very interestingly, Johns Hopkins, Roland Griffiths, who unfortunately passed away, he probably led the charge on this. They had a retrospective study 14 months after, heroic doses of psilocybin. They interviewed the individuals. And as I remember, about 70% of the individuals described it as an extremely positive experience in the top five positive experiences of our life. 30% of the people described it as a difficult experience. But the 70% of the people, 14 months later, they determined the act of re-remembering this experience was psychologically beneficial. They relived the experience. Well, that's reliving a memory. The 30% of the people who had a difficult experience, there was no adverse effects post the experience. 14 months later, they just said, not for me. I'm not going to do that again. That was too difficult. So people have schizophrenia, psychosis. Absolutely. This is truly a mind bender. But that so many people can benefit from this. And people need to realize this is the anti-addictive drug. So many people, when they take a high dose of psilocybin, of psilocybin, they look at the mushrooms the next day and they say, "No way, I'm not touching those." people use it one time in their life. One time. Think of that. This is why for opioid use disorder, for tobacco, for alcoholism, for all these addictive, for obsessive compulsive disorder, which is what we're involved in right now, this seems to reprogram not only the neuroscape, but we know there's dendritic tips being formed from the tips of the axons. And when these dendritic spines grow out and they adjacent axons and they touch each other, you have synaptogenesis. And then you have neuroplasticity of a new neural pathway in order to be able to think. You have another way of breaking your addictive behavior because you're not stuck in a rut. And that's what's so exciting is the neuroplasticity benefits of psilocybin. Everything we're doing right now, Andrew, is related to the health of our nervous system. Our seeing, our listening, our elocuting. Me trying to formulate thoughts. It's all based on the health of our nervous system. I think psilocybin will go down as a paradigm shifting drug rediscovered that could have the most dramatic impact for the health of individuals and society of any medicine discovered in history. That's what I believe.
Speaker 2That's a big statement. I spent some time with the clinical trials on psilocybin for major depression, a little bit on the data for OCD. And I should just point out, we're not talking about OCD of this person is really nitpicky. quote-unquote anal retent. We're talking about people whose compulsive behaviors actually strengthen the obsessions, and that's a vicious loop. It's very, very detrimental to everyday living. So if these things can provide relief, and the clinical trials are very encouraging, I'm on board. I do have a question. I just would like your thoughts. As you point out, mechanistically, we know that psilocybin can create new neuronal connections in the brain, maybe unmask existing connections as well, from what I understand. I've been intrigued by the sort of paradox where plasticity is great, but the directing the plasticity toward a particular endpoint, the resolution of the depression, of the obsessions, of the excessive ruminations, I mean, that's sort of the goal, right? It's not plasticity, it's directed plasticity. And there I feel like the qualified therapy plays a critical role, right? It's not clear that people can just kind of freestyle this. And so I think that for me, the big question in the psychedelic therapies realm is the experience of the psychedelics. Like the thoughts, they're unusual, you know, compared to everyday life. Are the thoughts, are the, is the therapy, is what we say and what we hear, what we think and what we feel during those psychedelic sessions, is that critical to the clinical outcome? Because ultimately, there's also a lot of neurochemistry happening that facilitates plasticity. So maybe we don't care about separating those two, but I think if people are going to use these powerful compounds to try and be healthier, I think it's going to be a big deal. I think it's going to be a big deal. I think it's going to be really important to figure out what should they be asked during these sessions. I don't think any of that is standardized. Like we can say more about dosage and strain than we can about what a good psychedelic therapy should look like.
Speaker 1Absolutely. It's so important. Let me just bring it back from my perspective. My father, who was anti, he was a pro-Nixon, anti-drug guy in his seventies, said, Paul, I want to do soul-savvy mushrooms with you.
Speaker 2How old was he? And he said, what, 74? All right. Call up your parents, folks. No, I'm just kidding.
Speaker 1It was like, I was blown away. You know, he'd never, the mushrooms somehow were different to him. You know, the father, considered the father of American mycology, Alexander Smith, also in his seventies, he published a monograph on the genus psilocybe. It contains most of the soul-savvy mushrooms. And he studied soul-savvy mushrooms all of his life, but never, he had eaten them. He asked me, Paul, I trust you. I'm going to do soul-savvy mushrooms with you. I have two father figures. And I turned them both down. I turned them both down because I knew the therapeutic element was so important. If they have this experience, and for listeners who haven't had this experience, you have what's only can be described, best described, we lack the words for this, is this oceanic experience where you suddenly, the ego dissolves and you feel connection with nature. And you feel connection with nature. And you feel in the universe. And you realize you're just a whirlpool of molecules that have formed in this body. And before you were born, you didn't exist. And after you die, you don't exist in the same form. But this unanimity of being connected to this big concept, you know, we can argue about what name to put on this concept or what this force is. But this oceanic feeling is a high PTSD and depression. The individuals who don't have this oceanic feeling, it seems to be correlated. They don't have the benefits. Therapy helps you. The reason why I turned down my father and Alexander Smith is the next day, literally, I was leaving. I asked both of their wives, will you also take soul-savvy mushrooms with us? Both of them said no. I didn't want to be the wedge in their relationship where someone has the most spiritual experience of her life. The other person has no. idea what they're talking. And then I, you know, disappear. You have to have a therapeutic support team. This is what Roots to Thrive. It's a model. Their program is up on the web. I highly recommend people look into Roots to Thrive, look at their model, follow their lead. You know, they do group therapy, six to eight individuals. It started with end-of-life anxiety, typically stage four cancer. It's been much more bigger than that now. But you end up with a community of souls, of people that you learn prior to the experience. This is their model. And then after the experience, they have new friends. They have new colleagues. They have a community of people that they can talk to. So many physicians, you walk out of their office, you're the patient, goodbye. And the patient goes, wait a second, I thought we were friends. No, you've always been a patient. So the Roots to Thrive model, I think, is a foundation of being able to economically efficiently do this, create, talk. Therapeutic, you know, benefits, not only with a trained therapist, but the individuals who have a shared common, you know, experience that they feel a new relief. So many of the patients in Roots to Thrive, you know, been told through my partner, who's one of the main movers of this, have become the therapists of their family, saying, I'm dying. It's okay. You know, don't be worried. And the family's going, what's going on here? Before they were anxious about dying. And now they're saying, you know, family, chill out. It's okay. I know what's going on here. And surprisingly, many of them are not dying. No clinical trial has been done on this, but when you're happier, your immune system upregulates. When you're depressed, you have an inflammatory state, your immune system downregulates. So it's mind over body clearly has an effect here. So the therapeutic element that you mentioned is absolutely critical. This is why, again, I want to say we have to be adults in the room about this. These are powerful medicines. These are not party drugs. We need regulation. I mean, it's surprisingly coming from me, but we need regulation because the dangers of not having regulation and purity and the therapeutic regimen, we don't want to fumble the ball on this. It's too much potential good for society.
Speaker 2Yeah. Well, I'll just say, and here I want to be clear, I'm revealing my personal bias, but with all the cautionary points that came up earlier in mind, amen to that. It's kind of ironic that the fastest movement that we've observed for the psychedelics in particular, again, and psilocybin presumably will be next in a non-psychedelic, the empathogen MDMA moving to FDA approval. They're not there yet, but it seems like they're headed there quickly has been through this alliance between let's just call it what it is, the left and the right. It's been, as I would now refer to them, the Ricks, Rick Doblin of the MAPS initiative and Rick Perry, former Republican governor of Texas joined arms in this and things are moving pretty quickly. Who would have thought during a Republican administration that psychedelics would get accelerated toward the FDA finish line, but they have not crossed yet. They have not crossed yet. I say this with optimistic anticipation, but it's really this bipartisan effort that has really made it happen. I don't think the Republicans could have done it alone and I don't want to speak for Doblin, but I don't think the left could have done it alone. It really feels like there needed to be sadly a mental health crisis and then the medicines to get us here. And it's very, very close. I think in 2027, I think we're going to see at least one of the three medicines I mentioned. I hope it gets
Speaker 1rescheduled to schedule two, schedule three, schedule four, as soon as possible. But what you're speaking about is most all of us have families. And we have families of diverse opinions, politically, religiously. Boy, my family is like that. My mother was an arch conservative. She was a deeply devout Christian. And I learned that in Christianity and in Judaism, there are psychedelic Christians now that do one dose of psilocybin and they feel like this affirms their religious beliefs. They don't have to do it again. But this idea, I think psilocybin makes nicer people. It makes us tolerant of each other. And we have so much more in common. 95% of us have the same common beliefs. It's the social media and these bots and clickbait to be able to exploit people getting pissed off or excited. or falling for it, this is really monetized and bringing out the worst in society. And I think what happens is this is a reboot of the system. And most of us have had family members or friends who've been afflicted with the opioid pandemic and the vets coming back with PTSD, having these heroic doses and then seeing these people change. It's good news. It's a pebble of the pond of positivity. You don't want to talk about your addictive relative or the negativity. That's something you want to keep quiet. When you see somebody heal and you can champion their cause, then you become a cheerleader. Like, oh my gosh, I was against this, like Rick Perry. And then he sees the benefit. He says, what was I thinking? And this is where it crosses the political divide. It is, it's, I can't help but say it's ironic. It's ironic that during this administration, they had the courage to do something that the previous administrations knew they should have done. But because of political blowback, they were afraid of losing their base or losing a few votes. So it's, it's, it's, we're at a new day. And I hope that this never goes backwards. I have, I think there's so much potential. I last want to talk about the near normals. So when you look at these studies, there's therapeutic use of psilocybin for treating people with mental health. Disorders or psychiatric disorders. We're all kind of on the spectrum. You know, we have good days and bad days. We have family member dies as a tragedy. So we all sort of are moving back and forth in this emotional, psychological spectrum. But what about all this near normals? What about prevention of addiction, prevention of PTSD, prevention of depression? This is why I'm going to say something very controversial, but I absolutely believe it to be true. When you look at the cost benefit ratio of prevention of addiction, you're going to see that the cost benefit ratio of preventing crime, preventing violence, preventing depression, addiction, PTSD, psilocybin mushrooms should be available for everybody for free because the return on investment to society as, as the many billions and billions of dollars, recidivism, reduction of the number of people going to courts, to prisons. This is a huge paradigm shifting potential breakthrough for society. It just makes more congenial, nicer, and I believe more intelligent. People, and we have a crisis in creativity. We have a crisis in immunity. And this is where the subject field is so exciting to me because I believe this for all these years, but now there's a lot of other scientists who are like, they say, yeah, this is true. There's 306 clinical trials on psilocybin at clinicaltrials.gov as of this morning. 306. That's impressive.
Speaker 2You know, the IRB boards, every one of them had to go through an IRB board. Yes, it's an institutional review board too. Make sure that there are safety measures in place because these are human clinical trials, lots of preclinical animal data as well, in vitro data.
Speaker 1When I say that you should be made free, you know, psilocybin mushrooms for the same time, my sister would never take a psilocybin mushroom, but it was approved by the FDA and was a pharmaceutical and she needed it and she would take it. So citizens has universality of views. There is plenty of people for both. Both the pure pharmaceutical as well as the natural form. But I think we do need to have intelligent regulation by the government. We need to set up programs. In Europe, for instance, all pharmacies and all pharmacists are trained to identify mushrooms. When you want your mushrooms identified in Germany, you go to a pharmacy and they're trained on identifying the best poisonous or the best edible and the best poisonous
Speaker 2mushrooms. Is psilocybin legal overseas? No, it's not.
Speaker 1But they're trained. They're trained specifically. That's kind of what we need. I think we need to have that sort of infrastructure, you know, where you want to do this. Okay, we have a week-long therapeutic program. Enter this, then you'll be given it. You'll have a follow-up, et cetera. And so many people, it's just once in a lifetime experience. If you can improve your life for the rest of your life, and it takes four to five hours, the investment in making your life fundamentally better for four to five years, four to five hours of investment is just a massive return.
Speaker 2I'd like to take a quick break and acknowledge our sponsor, Function. Function provides over 160 advanced lab tests to give you a clear snapshot of your bodily health. This snapshot gives you insights into your heart health, your hormone health, autoimmune function, nutrient levels, and much more. They've also recently added access to advanced MRI and CT scans. Function not only provides testing of over 160 biomarkers key to your function, but also gives you an overview of your physical and mental health. It also analyzes these results and provides recommendations for improving your health from top doctors. For example, in a recent test with Function, I learned that some of my blood lipids were slightly out of range. As a result, I decided to start supplementing with natokinase, which can naturally help reduce LDL cholesterol. And it did. In a follow-up test, I could confirm that this strategy worked. My blood lipids are now back exactly where I want them. Comprehensive lab testing of the sort that Function offers is just so important for health. I mean, how else are you going to know what's going on under the hood? And while I've been doing blood work for years, it used to be time-consuming, complicated, and expensive. In fact, I used to spend thousands of dollars per year trying to get this kind of data. And the data, frankly, were not all that good. But now with Function, it's extremely easy and affordable. A Function membership is only a dollar a day, $365 a year. And if you think about the information it provides and the health challenges it helps you avoid and the proactive things that it can do for you to enhance your health, I don't truly look at it as a savings. To learn more, visit functionhealth.com slash Huberman and use the code Huberman for a $50 credit towards your membership. Again, that's functionhealth.com slash Huberman. And as far as I know, the studies are only on adults. I don't know of any studies on younger folks, you know, younger than 18. And my guess is that they haven't been done or not in great numbers. I'm going to just put out a voice, not to protect me, but to protect whoever's listening and why I'm watching. The brain is very plastic early in life. Growing up is a psychedelic experience. I'm yet to be convinced that psilocybin has been shown to be useful in young folks. I'm not saying it can't be. I'm just, I'm not aware of any good data that would argue that people younger than 18 should run out and do psilocybin.
Speaker 1Well, as an abundance of caution, it's responsible for us to say that psychedelics are not for everyone and for very good and solid reasons. However, indigenous peoples all over. I have a common tradition of using psychedelics, peyote, psilocybin with younger people, and especially at the coming of age, you know, that 16 year old and Rick Doblin has talked about this with his meeting with the FDA. They are emphasizing, oh my gosh, MDMA, not only for couples therapy and resolution of depression, but prevention and treating younger people early on in their disease cycle could really make a difference later on. And so more studies, it
Speaker 2sounds like would be helpful in my mind. Can I ask you about micro dosing? I call the macro, you refer to as a heroic dose, two to three grams in many of the clinical trials done once or twice with therapy. Then there's the quote unquote heroic doses, four to five grams. What is a micro dose? Like what qualifies as a micro dose? Is it less than a gram? And how often are people taking them? I'm aware that you were involved in a study. Of micro dosing, self-report of positive and negative effects. And maybe you could summarize that study and tell us what constitutes a micro dose in terms of milligrams and frequency.
Speaker 1Everyone's different and everyone has different sensitivities. A micro dose by definition is subsensorium below the level that you feel an effect. That's what a micro dose is. In the psilocybin-cubensis scale, one gram at 1% is 10 milligrams, 10 milligrams clearly is a liftoff dose. A micro dose is usually one to three milligrams, something like that, for most people normalizing across the landscape.
Speaker 2People can feel 10 milligrams?
Speaker 1Oh, yeah. Oh, yeah.
Speaker 2Of the pure psilocybin or of mushrooms?
Speaker 1The pure psilocybin. Okay. That would be one-tenth of a gram. Well, one gram would be 10 milligrams. So, one gram of mushrooms is 10 milligrams. Right. This is very important. Very important. You want to repeat that? Well, one-tenth of a gram is one milligram. One gram. One gram is 10 milligrams. The hero's journey starts at 2.5 grams or 25 milligrams.
Speaker 2What is a micro versus macro dose in terms of the actual mushroom or broken down mushroom product? Not the pure psilocybin, but the mushroom itself. One-tenth of a gram versus five grams.
Speaker 1One-tenth of a gram of what? Of psilocybin-cubensis, of the mushroom. Okay. One-tenth of a gram is one milligram. Five grams is 10 milligrams. 50 milligrams. The FDA has approved 25 milligrams or 2.5 grams of mushrooms as the standard dose. That's why most all clinical trials are 25 milligrams now. 2.5 grams of psilocybin-cubensis
Speaker 2at 1% concentration. Yeah. So, let's just highlight that last statement. They are 2.5 grams of psilocybin mushrooms at 1% concentration. Is 25 milligrams. Right. So, this is so important because when people hear, you know, 25 milligrams or 2.5 grams, that's it. ENORMOUS. difference. So they're talking about the actual mushroom versus the chemical in the mushroom.
Speaker 1Yeah. Realize that 99.9% of the uses of psilocybin is in psilocybin in the mushrooms. And just a few hundred people, maybe a few thousand people now have taken psilocybin in the molecule. So the real world use of psilocybin is in psilocybin mushrooms, which has all these other tryptamines are involved. And so there's an entourage effect. We published, Dr. Pam Crisco and colleagues published a paper on four individuals who took both the psilocybin in the molecule and the psilocybin mushrooms in a natural form or an extract thereof. They interviewed them and all of them preferred the natural form. The pharmaceutical had a quick liftoff. It felt chemically and then had a quick descent. Sounds like most pharmaceuticals. Most pharmaceuticals. The psilocybin mushrooms had a little bit delayed, but also quickly. Quick takeoff, but had a long tail. And that long tail, the patients felt it gave them time to reflect. Some of them reflected that they felt like they were connected with the natural world. Now, when you go back to psilocybin, its lineage goes back, the molecule goes back to Albert Hoffman in 1958. When you're taking the mushrooms, you realize there could be several million people on the planet at the same time taking psilocybin mushrooms. You are taking a journey with a collective consciousness of millions of other people who are simultaneously entering into this space. Your lineage goes back centuries, thousands of years and communities across cultures. So the sense that you're part of this community that goes back in history, that's tied to nature compared to a pharmaceutical, which is great, but as one patient said, if I only had the pharmaceutical, okay, it works. I would take it, but I prefer the mushrooms. That's illustrative of where we need to go. Standardization is important because you need to be able to understand what you're taking, but just your very diet affects your sensitivity to these substances. So let me go back to microdosing. There's microdosing, medium dosing, and the high dose, therapeutic dose, the macro dosing. The sweet spot that we're increasingly paying attention to is medium dosing.
Speaker 2And maybe just in this context, what is that?
Speaker 1Mushroom weight, that would be on the order of a half a gram, okay, which would be like five milligrams, okay, of pure psilocybin. It's oftentimes called the museum dose. You know why it's called the museum dose? No. It has been a common practice for a group of friends in the near normals to take a small amount of psilocybin mushrooms and then go to a museum. And you may have encountered these people, occasionally. They're unusually happy. They're visually stimulated by everything in the museum and the artwork, but they typically wear sunglasses because the pupils of their eyes are so dilated, they took off their sunglasses. It would scare people. They have no bites in their eyes, but it's called the museum dose. I say that because it's a liftoff dose. It's a sensorium, but it only is sensorium for a very short period of time. And I don't like making the analogy to alcohol, but I don't know what else to use. It'd be like, drinking a half a cup of wine real fast. And you feel a little bit of a liftoff for a few minutes, half an hour, and then it goes down. But this is not the five hour deep journey. The sensorium dose, we think it's important because activating the 5-HT2A receptors, you're actually engaging. There's more 5-HT2A receptors in your gut. And the vagus nerve connection with the mitochondria cascade that's occurring from the vagus nerve, it's not even been explored. We're all talking about the prefrontal cortex or 5-HT2A. Psilocybin is a prodrug for psilocin. So 10 milligrams of pure psilocybin is 5 milligrams of psilocin. Just to simplify things. Just to simplify.
Speaker 2Yeah. I'll just briefly clarify if it's confusing anyone that the prodrug is causing the release and activity of this other molecule, which is then the bioactive molecule. And you mentioned the 5-HT2A receptor is a particular category of serotonin receptor, which seems to be the basis for a lot of the therapeutic effects of, let's just call them what they are, magic mushrooms.
Speaker 1Yeah. But there's also tract B engagement. That's the area that- Yeah. We'll talk about the receptor for BDNA. Yeah. That's also, so there's more than one receptor group that's being engaged. But so the museum dose creates a liftoff experience that's sensorium, but it's not intoxicating. You feel it, but I wouldn't really say you're intoxicated. You just kind of feel it. And then it goes away. You wouldn't want to drive. No, but there's so many reports of extraordinary athleticism. And I hear it. I just heard it yesterday. What forms of athleticism? There's all sorts of them. There's some really fun ones. Yesterday, I heard about a person who's a professional dart player, throwing darts. And I told him about the museum dose. And he came up to me and goes, "Yeah, I'm a professional dart player. I do the museum dose."
Speaker 2Sure he doesn't think the bullseye's over there when it's actually over there? I'm just kidding. I'm just kidding.
Speaker 1There's many examples of this. I can tell you one or two stories that are pretty extraordinary, but there is evidence of this. Of course, it's dangerous for most people. I'm not advocating it. Please don't do this. But there are individuals who reported exceptional athleticism from martial artists, to boxers, to people involved in baseball, across the landscape.
Speaker 2Don't experiment on game day. Yeah. Well? Isn't this the golden rule around all substances and performances that you. I don't want to inspire anyone to do anything they wouldn't otherwise do, but that you don't want to compete. Best competitions tend to emerge under the similar conditions to which you practiced. So this was this idea. Years ago, I took a psychopharmacology course, and I distinctly recall the instructor saying, "People who studied drunk, performed better drunk on their exams than they did sober, but still worse than all the people who took their exams sober." So it's a complicated recipe, but I get your point, that it maybe is allowing people to access a plane of mental and physical performance that they couldn't otherwise.
Speaker 1Well, you've developed muscle memory and skills. So once you develop those skills, that there's a muscle, the psychomotor benefits enhanced by psilocybin becoming a psilocin and blocking with the receptors. We know that visually, you have a lot more information. Hearing seems to improve. I mean, those of us who have done psilocybin mushrooms and psilocybin, the colors, everything lights up. I mean, that's because you're seeing more of the spectrum. You have more neural activity and you're. It's not artificial. This is the thing that's weird. Back in the day, in the '60s and '70s, psychedelics were thought you're seeing a non-reality. You're seeing something that doesn't exist. Now, most of us believe you're seeing reality in a better way. And more clear than you've ever seen it before.
Speaker 2Yeah. And as a neuroscientist, I think, if I may, I think we should highlight what exactly that means. Our sensory apparatus, our eyes, our ears, our touch receptors in our skin and so forth, are extracting a pretty narrow wedge of physical information in the world. And then creating these abstractions in our brain of what's out there. And on psilocybin, there may be a wider wedge. In certain. An integration of different senses. Certainly, there's more perception at the level of overlap between the senses. Some people experience. Many people experience synesthesias on psychedelics. I certainly have, where you touch something in it and the contour of that surface matches to particular frequencies of sound. I mean, that's not uncommon, right? Which is a form of synesthesia. May I ask about the benefits and any potential side effects that were observed in this study on microdosing? Because I know it's one of the few large subject number studies, of microdosing. And I know you were involved in this study, so I just would love to highlight that for people. Well, yes.
Speaker 1I was with my colleagues as a quantified citizen out of British Columbia. I think we got up to 25,000 participants. We published two papers in Nature, the scientific reports, observational studies. These are self-reporting. They were given, basically, they enrolled. They created a baseline and the motivation, why you're taking psilocybin, how much you are taking, what are you combining it with, et cetera. The first paper we published in Nature, we heard back from the editors what they really liked about it. It was the two groups are so well-weighted. We had more non-microdosers than we had microdosers in the study. 4,500 non-microdosers, a few hundred less microdosers. So that was extraordinary. People were motivated to do a test and we had more non-dosers. And I thought, well, maybe they're trying to create their baselines or something like that. I would. You're a little citizen scientist. This is a citizen scientist effort. So that may indeed be what was happening. But of course, the results showed tremendous improvement against depression and PTSD and anxiety. Those are the ones that really were significant in the measurements. Now, the blowback is expectation. Now you're in a community of individuals, you're sharing this experience. And so how does expectation. Well, every medicine has a coefficient factor of expectation. You go to a doctor expecting to get a A treatment so you feel confident in the therapy. Sure, the placebo effect is real. So, yeah, the placebo and the nocebo effect. What was really interesting is I intuited that we can enhance psilocybin's benefits if we bundle it with niacin. Because psilocin is a vasoconstrictor. Niacin is a vasodilator. Vitamin B3, this is the flushing form of niacin. Because vasoconstriction neuropathies oftentimes present themselves as deadening the fingertips and the toes. Because of vasoconstriction, the neurons get starved of blood and they atrophy. So, I thought the flushing form of niacin, when you take it, you feel itchy, you get red. It's a vasodilator. So, if you're going to offset neuropathy, why not have a vasodilator with psilocin, which is a vasoconstrictor? So, you get more blood and more psilocin to the endpoints of the vasodilator. The peripheral and the vascular nervous system. So, I came up with something called the Stamets Stack. And I named it after myself. Doctors can name diseases after themselves. I named it after myself because I was tired of getting ripped off. So many people would take my ideas, rip it off, and they wouldn't ever give me credit. So, I'm just going to tag this thing. So, I'll call it the Stamets Stack. And it's psilocin or psilocybin, niacin, and lion's mane, mushroom mycelium. So, in this Nature Scientific Reports study on microdosing, there was significant measurement of increase in mood and decrease in depression and anxiety. But we were criticized that this is all the placebo effect of expectation. So, I asked my colleague, Dr. Pam Crisco, don't we have something that's not related to expectancy or is outside of this argument? And she said, yes, we have the psychomotor test, the tapping test. How quickly can you tap your tooth? Three fingers in 10 seconds. And so, we put the tapping test in the microdose.me app that people could then measure. And so, what was amazing is compared to non-microdosers after 30 days, and there was a learning period for a few days so you could practice, with the non-microdosers and the people who took psilocybin at a microdose level, you know, again, we're talking a tenth to a third of a gram of psilocybin commences. And then those people who took psilocybin at a microdose level, those people who did the Stamets stack, in 30 days, the tapping frequency for the stackers went from 43 to 63. That's a psychomotor benefit. You can't say that you had expectation increased, you know, the tapping frequency. And that really struck me as, oh, my gosh, this helps your nervous system. Think about walking. Think about typing. Think about playing guitar. Think about a teacher trying to play the piano and teaching when they're older. The digital ability to demonstrate the psychomotor benefits. Think about not falling and going to the bathroom as you get older. I thought, oh, my gosh, this could be just a neurological tonic that can help improve your basic neuro-escape. And so that's what is so exciting about us. Now, unbundling this, is it the niacin or is it the lion's mane? I'm increasingly thinking that niacin is a force multiplier. And ironically, it's like the herd mentality of scientists at clinicaltrials.gov. There's 306 clinical trials, and there's at least 20 that use niacin as the active placebo, teaching oppositely because the flushing occurs in 20 minutes. They want to make sure some people felt something. So people are sort of teaching away from what I'm advocating. But I think niacin is an amplifier. I think lion's mane also adds another dimension to this for remyelination. But the dendritic spikes that are spines that are being formed, I think, are autoimmune. And so I think that's one of the things that I think is really important to talk about in this podcast is that I think that's one of the things
Speaker 2that I think is really important to talk about in this podcast. Let's constrain this walk, as we say, because this is a vast discussion. What are some very top contour statements that you feel comfortable making about the role of fungi in improving memory, cognition, and some basic known mechanisms? I mean, I realize we could do the deep dive on this track receptors, and we probably should at some point. But what about cordyceps lion's mane for cognition and memory and for just daily activity? So now we're not talking psychedelic mushrooms. We're talking cognitive. We're talking cognitive enrichment of some sort.
Speaker 1Well, I would refer people to mushroomreferences.com, HTTPS colon slash slash mushroomreferences.com, or just Google it, you know, mushroomreferences.com. Those are peer-reviewed articles. Cordyceps is really a big bucket because there's multiple species and great scientists. And this is a really cool story in many ways. It turns out that when they did DNA amplification, they got five different species left. They're coming out of cordyceps sinensis fruit body in the Himalayas. And when they cloned, these scientists were good. They knew what they were doing. They would take a cordyceps, this is stroma, and they would break it, and they would take a piece of tissue inside, and they'd put it on a petri dish. And they'd get this fungus to grow. Oh, I got cordyceps. Well, that's true of the oyster mushrooms. That's true of shiitake. That's true of the garacon. But it turns out that in this stroma, there are multiple species of fungi that are coexisting. And so one of them was cordyceps sinensis, and then it became ophiocordyceps sinensis. And the other one was hirsotula sinensis. The other one is bacillomyces happyale. And so you kind of have this war going on with mycologists, you know, saying, I got the real cordyceps. No, I got the real cordyceps. So it was very interesting. Now, cordyceps militaris is also another cordyceps. That one is very easier to grow. So cordyceps militaris, the problem with a cordyceps sinensis record. We don't know which cordyceps they're actually studying, you know, so it gets really complicated. What we do know is that it increases the neticene and oxygen uptake. So the study that's most believable, I think about 73 patients with cordyceps militaris, they prime themselves for two to three weeks, and it increases the ability to perform.
Speaker 2So they're taking cordyceps at gram dosages, milligram dosages? Yeah, gram dosages. Is time of day relevant here? I can't speak. We can provide a link to the study. I'm just wondering whether or not these are acute effects where people can take this, you know, an hour prior to doing some creative. I don't think it happens that fast.
Speaker 1With reishi mushrooms and sleep, I think that does happen. So reishi mushrooms can enhance your quality of your sleep. Lion's mane mushrooms also, cells take time to divide. And this is why the heroic dose of psilocybin versus titrating it with medium doses, if it's going to be neuro-stimulatory, it can't be one spark, and that's the end of the story. I do a lot of cell culture work, and the mycelium grows out like neurons. And I always thought, wow, these are like neurons, but it takes time for those cellular divisions to occur. Sure. So titrating, you know, these medium doses, it takes time also with cordyceps. Clinical studies are very expensive. And what's the motivation for a clinical study if you don't have protection of IP? Who's going to make the investment? And so it's very difficult to find phase two studies. So several phase one studies, they cost a million and $500,000 to $2 million apiece, typically, depending on the cohort and the size and what they're doing. They're safety studies. The phase two studies looking for an effect, they're in the $5 million to $20 million range. You know, there's just a lack of funding. There's not the vehicle of profitability and investment in intellectual property to get these studies funded. So the lack of studies should not impugn the potential effects of these. It's just a fact. The economic. Landscape does not support natural products research to phase two, phase three. Artemisicin came from Artemisia, active against malaria. That's a great example of a natural product, you know, that didn't make it through clinical trials. So lion's mane and cordyceps, it takes time for these effects to be seen and oxygen intake and performance enhancement occurs over time. It's not an immediate thing. You know, coffee can wake you up in one or two hours, but it's not going to actually, you know, be beneficial in the long term, you know, the effects that we're trying to talk about here.
Speaker 2And I'm grateful that you pointed that out because I think a lot of people have encountered products where if cordyceps and we'll take it thinking there's going to be a cognitive enhancing effect and it makes perfect sense to me now why, in many cases, it wouldn't have that acute effect, but when taken continuously for some period of time, it might, you know, you're not going to be able to take it for a long time. You're not going to be able to take it for a long time, you're not going to be able to take it for a long time, you're not going to be able to take it for a long time, you're not going to be able to take it for a long time, you're not going to be able to take it for a long time. internet and a few studies on things like grounding and, you know, putting feet on the ground and electrical grounding and magnetic fields. And as somebody who's like deeply embedded in the research on and practices on circadian biology and sunlight, et cetera, to me, it's not that wacky, but we need more data or maybe we don't, depending on what one's threshold for putting feet onto the moss or to the ground. I'm very interested in how fungi might have electrical signaling both between each other and with other organisms, meaning us. And I'm just fascinated by this idea that there are electrical fields being passed laterally, but also to other organisms through these fungi.
Speaker 1Well, I postulated that mycelium will be microcomputers in one of my books in 2004, Mycelium Running, How Mushrooms Can Help Save the World. I was lambasted, you know, of course, by the critics and skeptics. Now we know there's 50 word packets that have been discovered, discrete word packets. of electrical packets that are being signaling through mycelial networks. They are conductive. They hyperaccumulate heavy metals. We know that these are electrical signals that are passing that alert the mycelium to food, to predators. And we don't know exactly what all the words mean, but they're distinct word packets. Anyone can look this up. We know 50, like immediately, oh my gosh, you know, 50 word packets and combinations, you know, do the algorithm, how many potential sentences can you create? So we know this is signaling is going on. And I think we are in constant biomolecular communication with our ecosystems. So the mycelium being an externalized neural network, you know, I described it as a, not only a neural network of signaling, which we know now to be true, it's an externalized lungs because they're exhaling carbon dioxide, inhaling oxygen. They're externalized stomachs, you know, because they digest their nutrients externally. This is a very efficient structure for accomplishing three things. Our neuroscape and that of the neuroscape of mycelium, I think this is the future. I have just been in communication with one of the owners of Clark Shoes. We started jamming on these ideas and some ideas I had to shoot down. It didn't work. But the idea we started focusing on is, oh my gosh, you know, since every footprint that you take, you're stepping on literally like hundreds of miles of mycelium. If you could create a neural net interface with your shoes, you know, you're going to be able to do a lot of things. You're going to be able to do a lot of things. And then with your mycelium-like garments and with hats, you will then become these neurological membranes that are connected with nature, both for weather systems, for contact with celestial signaling gamma rays from a galaxy. I'm not going to go into the UFO space. What I'm just saying is that you could extend your neural sensitivity networks by using mycelial interfaces. And the idea of being able to walk across the universe, you know, you're going to be able to do a lot of things. And then with your mycelium-like garments and with hats, you're going to be able to do a lot of things. These neural networks and the mycelial networks are constantly in communication, constantly in competition. What if we start seeking alliances with these mycelial networks in nature? What will that do to expand our consciousness of nature and tapping into the deep intelligence of these mycelial networks? This is where AI could come into place. Now, obviously, if it's raining, it's going to be more conductive. How would the membrane be? Would be copper meshes? What would the interface be? This is just the beginning of this. This is just the beginning of this idea. I'm sure there's lots of young scientists who could take this idea and run with it, you know, and whether the shoes have spikes in them so they go subsurface, you know, there's all sorts of elaborations on the idea. So we know these mycelial networks are neural networks now. It sounded crazy back when I described it. Now other scientists are saying yes. It's funny. I do take some pride in the fact that a lot of my ideas were very fringe, are now considered to be exceptional. Except in science. Well, of course that's true. And it's like, okay. When I was first saying this, it was looked upon as a crackpot. Now scientists are saying, absolutely, this is true. This is the pace of science. Where we can go with this, I want to share something with you. There are some things in life that you know are true. And it dawns on you. It's like I mentioned the crack in the cosmic age by Joseph Pierce. It's when you study a subject so much, you suddenly have that intuitive insight. I mean, test me, folks. I don't know if this is going to be true. You might have to wait a few thousand years and retrospectively, you know, confirm this in the future. But I'm an amateur astronomer, capital A amateur, capital A, small a astronomer. And I really wanted to be an astronomer before I became a mycologist. I'm just blown away by the cosmos. And we're here on this planet and we're a coincidence of all these light beams that are galaxies that have passed on or morphed into a different thing. But we're a coincidence of all these light beams coming in. And there was an amazing discoveries that have been made on asteroids in the past 10 years. First, a Japanese asteroid retrieval from a probe brought back and we found the basic amino acids that build DNA, you know, ACGT. But another asteroid retrieval is especially interesting. And it's called the asteroid Bennu. In 2016, NASA sent a probe to Bennu. Took two years to get there. Took about a year and a half of it circling the asteroid to figure out where it's going to land. They want to optimize. I think it came to the Renaissance Plateau or something like that. So they landed the probe, they retrieved some asteroid dust, dug into it. It took about two years for it to come back. And then November of 2025, NASA announced, not only did they found the amino acids, there's 14 essential amino acids been found so far, but they found something else. They found another amino acid. They found tryptophan. They found tryptophan on Bennu. Tryptophan is very fragile. So the other asteroid retrievals and meteorites coming in, they couldn't find this amino acid. But they found tryptophan.
Speaker 2Precursor to serotonin.
Speaker 1Tryptophan decarboxylates, liberates carbon dioxide in one chemical reaction, very, very simple, into tryptamines. Think about it. Think about it, Andrew. We have tryptamines throughout the universe. We have serotonin, likely, throughout the universe. These are tryptamine alkaloids. These are happiness molecules. The entire universe is likely filled with tryptamines. And if we have these networks of cells generating tryptamines, it dawned on me that we live in a tryptamine universe. We live in a universal field of consciousness. And we'll find mycelial-like organisms throughout the entire universe because that is the way. That's the way of our neurology. That's the way of mycelium. That's the way of the computer internet. That's the way of dark matter. We may live in this one giant universal consciousness, and we're tiny little apes who are looking up into the sky trying to wondering, WTF, what's going on? This, I think, unifies all religions. It unifies scientists who are becoming increasingly more spiritual. But we live in a tryptamine universe. To me, this is mind-boggling. It makes me feel much better about my own mortality. I'll be sad when I die, in a sense, but I'm returning to the giant universal consciousness from which we came from and of which we are a part right now. So this is what I believe intuitively as a fundamental truth.
Speaker 2It's about the brain and biology, while many of them are accurate, are certainly incomplete. So the openness that you have and these observations, which are coming in faster and faster all the time, is exciting.
Speaker 1But let's be serious scientists. Where's the proof? Where's the logic in this? Let's stress test this. And this is what I'm seeing over and over and over again, these extraordinary imaginative concepts. And we can dare to be wrong. It's important that we dare. It's important that we think creatively, not constructed by tradition, but try to question. I had a sticker on my car for a long time. It was question authority. And I put it underneath question authority with respect and humor, you know, because I thought that's the way you create a dialogue. You don't insult somebody. You question them and you ask them, why do you think this way? And both of you can create a dialogue. And your imaginations are stimulated. And you build a bridge of communication going, you know, I haven't thought of that. So I just think that we're at this time of great imagination. And this is a time to potentiate the imagination of humans. And I think psilocybin and these mushrooms are force multipliers to expand our immunological and neurological health.
Speaker 2I have a question about these electrical fields. You talked about a hypothetical arrangement where we had spikes. that would go into the ground, and you could transmit those electrical fields into the body. chemicals and electricity. I think people know this, but that's not a mystical statement. That's how neurons work and that's how our body and our cells work, but especially neurons. The notion of electricity in the brain, et cetera, hopefully doesn't make people think, oh, this is really out there. That's a fundamental concept. You know this, but it might be helpful to remind people of that. So that's us getting closer to and more direct interface with these electrical fields. What about the electrical fields and the chemicals from these fungi living in us? Most people nowadays have heard of the microbiome, these microbacteria that live in us that can be beneficial or in cases of dysbiosis can be harmful and on and on. And the critical importance of those for creating molecules that serve our brain and body and immune system and on and on and on, et cetera, et cetera. You've talked about elsewhere that the microbiome or mysobiome, we have- We have fungi living inside of us.
Speaker 1We have a lot of fungi living on our skin. Our skin is one of our biggest organs. And the microbiome of the skin gives us a homeostasis of protection against disease. It's when we use, in particular, antifungal antibiotics, it can really disrupt the microbiome. And I have, unfortunately, a horrible story of a friend's father who took an antifungal medicine and had an allergic reaction. And he got thrush, got candida. And he was a big, strong man. And apparently, his death was so painful. Brutal. Because it's brutal. That's an example of the danger of some of these pharmaceutical antifungal. We're more closely related to fungi than any other kingdom. And so, we share in common many of the same pathogens. So, we use antifungal medicines. This is why it's so hard to get rid of fungal infections is because they also tend to be cytotoxic. So, the microbiome on the skin is something that's being greatly explored. The microbiome internally in the gut is much poorer in our understanding right now. So, I can't speak authoritatively on the microbiome internally. Eukaryotic fungi, the eukaryotic cells of humans and fungi look very, very similar. We're using the bacterial mitochondria as our engine, you know. But typically, fungi living in and in between your cells is something that is not good, you know, from my limited understanding. So, the microbiome on the surface and the microbiome in your gut, that homeostasis is really important. The disruption of that is extremely dangerous. And so, this is erring on the side of caution. Just don't screw around with antifungals because the disruption to homeostasis can be extremely, extremely bad. So, I don't have an authoritative answer for you. And what I like to admit is when I don't know something, I'll tell you.
Speaker 2No, it's very clear that you are more than happy to stay within your domain of expertise and reveal when you're not.
Speaker 1There are other experts, though, out there. And please, I would consult them. They're usually discoverable. They are publishing a lot, especially the American Dermatological Association has a lot of interesting ideas on the microbiome of fungi that are living, are on and within the skin cells.
Speaker 2Two more questions for you, if you're willing. The first one is the potential benefits of fungi for cleaning up the planet and maybe even food supply. So, the ability of fungi to digest, to break down other things is pretty remarkable. And I think nowadays, most people in our egocentric old world primate expanded forebrain cells are thinking like, okay, there's no way to avoid microplastics completely. There's no way to avoid the tire particulate that's out in the air. You just can't do it. We're exposed to it all the time. But most people would like to reduce the toxic burden of these things. Is there a way that fungi can be put into the environment in beneficial ways to clean the air, to sequester and maybe break down some of these compounds?
Speaker 1I have literally spent millions, if not tens of millions of dollars on this subject. And I don't want to be a buzzkill, but I can tell you what I've learned. And it's been painful and expensive. We have very good, reproducible, demonstrable examples that we have published on of mushroom mycelium, like oyster mushrooms breaking down hydrocarbons, diesel, gasoline, bunker sea oil that the ships are burning from oil spills. Really good. The mycelium takes these carbons, PAHs, it breaks down them at the elemental level and it reassembles them into fungal carbohydrate sugars. I mean, it's almost that simple. So really good examples. I work with Battelle Laboratories for years. We broke down bunker sea oil, I think 20,000 parts per million to 200 parts per million in 16 weeks using oyster mushroom mycelium, approved for freeway landscaping and passed the Department of Ecology tests for that. Really good. So that works. So oil spills, mulching, mushroom farms should be reinvented as micro-remediation supply centers because the waste substrate after the mushrooms form, you can milk it like a cow. It is so full of so many powerful enzymes that can just break down complex molecules. So for that, that's really, really good. Dioxins, breaking down dioxins, PCBs, polychlorinated biphenyls, from my research, has been a disaster. But it's very illustrative because even though we could break down the dioxins in a petri dish in a laboratory, when we starve the mycelium, when you put it out into the ecosystem, think of it this way. It's like you have a buffet table and you're the fungus and you're hungry. And you have all this delicious food on the buffet table. And at the end of it, this toxin, dioxin, what are you going to eat first? Well, you're going to eat the delicious food if you starve the mycelium or break down the dioxin. So dioxin remediation to me, that's not practical. Similarly, breaking down plastics. There are some really good examples that have been published for breaking down plastics. Similarly, you throw the mycelium in an ecosystem, it's going to navigate to the foods that it's most desirable. And plastics is not something that is high on their list of desirability. So I wish I had good news on dioxins and PCBs and on plastics, but some of these recalcitrant, especially these polymers, that are very tightly bonded, what's the incentive for the mycelium to go after microplastics, which are a small percentage of the food buffet that it has in front of it? I mean, it's just like you and me, right? If you're going to go eat something on a buffet, what are you going to choose? So yes, you can. The untapped resource is mushroom farms. They're a waste substrate. How? You can compress it. It gets this beautiful amber, super high in the complex enzymes. And then you could re-inflate it by adding water. And the mycelium then can produce another. So I propose this in my book, Mycelium Running, is that mushroom farms should be reinvented as micro-remediation centers in every small city because you could add. The other area that's been very, very successful is microfiltration of E. coli and other contaminants associated with runoff. The mycelium is a filtration membrane. Very good examples. Also been published in several peer-reviewed journals of the mycelial networks capturing E. coli, preventing effluents from farms, chicken farms, cattle ranches, et cetera, from going into riparian sheds. So the good news is hydrocarbons in general, pesticides can be broken down, even things like VX, nerve gas agents where there's chemical spills. Many of these things are very fragile when the enzymes in the mycelium make contact. So microfiltration of bacteria, breaking down of these chemicals I just mentioned. The bad news is the dioxins and some of these other compounds. And mycelium does have the ability of sequestering radioactive particles and binding them in a way that is not soluble into water. So it can immobilize some of these toxins. That's a whole different approach, is the immobilization to prevent it from getting into the food chain. So when people approach me on this stuff, I'm like, oh, I don't know. I don't know this stuff. I just have to bite my tongue because I spent so much money with great scientists. We have some fantastic successes. But the reality is where I'm going to spend my valuable time, I'm going to spend it on optimization, on longevity, on making people nicer people and creating generations of happiness. Because the pebbles of the pond of happiness and positivity that we create now will reverberate into the generations of the future.
Speaker 2I certainly second that choice because it's benefiting so many. One last question. Let's talk push-ups. How many push-ups are you doing each day? I did 95 this morning. You're very vigorous. This is why I asked. Maybe share your longevity protocol.
Speaker 1I need to lose some weight. I've been on my bike in the past two weeks. It's a good story because my twin brother, my twin brother's name is North. So of course I was called South. His N-O-R-T-H is his middle name. Very competitive fraternal twins. So it's different. Different as two twins can be. But we were extremely competitive. That was a good thing about having a twin brother. So we started doing these marathon push-ups since I was like 10 years of age. And actually, I won the push-up contest in Columbiana, Ohio. I know my record stood for about 10 years. I'm not sure how long. But I was a freshman in the ninth grade, and they opened up for ninth, tenth, eleventh, twelfth graders. So lots of guys bigger than me. And they had a push-up contest. My twin brother and I said, oh, we can do this. And so we went in to do the push-up contest. And we're ready. We're ready. And as you probably know, that first 10, 15 seconds is really important because you spend a lot of energy getting up, getting going. And I started doing push-ups, and the coach stopped me. He said, after 20 seconds, I already did like 30, 40 push-ups. And he said, no, your nose has to hit the auditorium basketball floor. And so he laid down to see if my nose would hit because he thought you're doing them way too fast. And so I had to go touch my nose. And so I started doing the push-ups. And I ended up getting a bloody nose. And I had a push-up like 40, 50, 67. I have blood splattering all over the place. And I did it. I won the contest. And the record held for a long time. But I point everyone to a Harvard study. Please look this up. It's really extraordinary. Men can do 40 push-ups. I'm sure it translates to women, a different number, of course. But if you can do 40 push-ups three times a week, you have a 97% reduction. And the potential for cardiac arrest. Are all those push-ups
Speaker 2done in a single set? Single set. Single set. With a pause and continue or just continuous?
Speaker 1You have to look it up. But the study, I've looked it up many times. I've referred to it to many people. Fact check me. This is true. Full disclosure, I don't hyperextend my push-ups. I don't go with the nose to the ground. I go because I don't want to hyperextend my elbows past my body. So I'm about this far off the ground.
Speaker 2To break 90 degrees at the elbow? Yeah, break. Yeah, yeah.
Speaker 1I mean, just my comfort. I know when I hyperextend because my elbows hurt later on. But I just advocate this. This is like you want actionable solutions. This is probably the most actionable thing that anyone can do, women included, is to do push-ups. You do a stress test, you know. And I just came from several conferences that are biohacking. And, boy, I'm learning a lot that I didn't know. I think these chair sit-ups, you know, deep squats are something I'm going to start incorporating in. But I'm 71 years of age. I have no prescription drugs. I feel like I'm 35. I look at the—I was born July 17, 1955. I'm going, I just can't believe I'm 71 years of age because I look through these eyes and I don't feel it, you know. I don't feel cognitive decline either. But I attribute that to my use of these mushrooms because they're neuro-anti-inflammatories, in my opinion, and of one study. But I just really believe— And plus, the excitement of the field that you are in, you know, breeds creativity, breeds conversations like this, and upregulates my immunity. And it's anti-inflammatory by definition, right? So happiness is the anti-inflammatory drug. Ultimately, that's what we're seeing.
Speaker 2I certainly believe that. Curiosity, driving, you know, constructive, productive inquiry, community. Paul, thank you so much for coming here today to discuss here. Your discoveries in your work and the applications you provide, a lot of actionable steps for people to explore and consider. And also just a lot of—I was going to say seeds, should we say spores—for, you know, exploration in mental health, in immune system function, cognitive enhancement. And I have to say your enthusiasm around the tryptamines in the universe concept is one that certainly sparks a lot of interest. In me and in many people. And I haven't done DMT yet. I don't know about you. But I think it's fascinating. It's clear to me, if I may, that you are very unusual in your ability to think about very high-level, literally galaxy-and-beyond-wide concepts. They then come right down to the highly reductionist view and go back and forth, traveling back and forth, which is unusual. And I will say it no doubt has fueled the forward progression of this. This area of science and medicine. Very, very, very kind. Well, you're very humble, and I'm not quite done, so forgive me. I know this might feel a little uncomfortable for you, but I think that having studied a lot of the history of science and medicine and public health, et cetera, and the way it's progressed, it's always required somebody like you to be able to not just straddle, but really travel back and forth in the same conversation from these high levels, at times somewhat abstract, putting out their concepts, but then get right back to the grounding of things and explain what we need to know in addition to what you are intuing based on your knowledge and what we already know. So it's a remarkable thing. You mentioned end of one. You are an end of one. And I and many, many other people are extremely grateful. And I'm sure that will be true across time for the work that you're doing. And thank you for taking the time to come share your knowledge.
Speaker 1Well, thank you for being a fellow Ed Fronter. And I just want to call out to everyone, be creative, because creativity breeds happiness. And it breeds community. And then you have the crosstalk of all these receptors that are all in communication and dialogue. This is an opportunity for us to reinvent the human species, to optimize. And I think that we have all the elements here. And so I would just caution everyone, including myself, be careful about criticizing people until you understand why. Ask the question, why? Never take anything that you don't know. Take anything that you hear as a fact without asking the question, why? With humility, respect, kindness, and engagement. That's how you build these bridges. And our neuroreceptors want to talk to your neuroreceptors. We're all in this together. So I think that we have an opportunity for a collective genius to come together to find the solutions that we so need. And I really feel it's so important. And I know First Nations. I mean, they should get the concept of seven generations. It's so true. It's so important. Indigenous peoples have had the wisdom that scientists are now proven to be factually true with a different language. But the endpoints are the same. We have a duty to our descendants to do the best that we can. It's not what you make in your lifetime. It's a legacy that you leave. I think all of us can be part of a wonderful legacy if we work together.
Speaker 2Amen to that. I don't have anything to add. Perfectly stated. Thank you. Thank you for joining me for today's discussion with Paul Stamets. To learn more about his work, please see the links in the show note caption. If you're learning from and or enjoying this podcast, please subscribe to our YouTube channel. That's a terrific zero-cost way to support us. In addition, please follow the podcast by clicking the follow button on both Spotify and Apple. And on both Spotify and Apple, you can leave us up to a five-star review. And you can now leave us comments at both Spotify and Apple. Please also check out the sponsors. You mentioned at the beginning and throughout today's episode. That's the best way to support this podcast. If you have questions for me or comments about the podcast or guests or topics that you'd like me to consider for the Huberman Lab podcast, please put those in the comments section on YouTube. I do read all the comments. And if you're not already following me on social media, I am Huberman Lab on all social media platforms. So that's Instagram, X, Threads, Facebook, and LinkedIn. And on all those platforms, I discuss science and science-related tools, some of which overlaps with the content of the Huberman Lab podcast. But much of which is distinct from the information on the Huberman Lab podcast. Again, it's Huberman Lab on all social media platforms. And if you haven't already subscribed to our Neural Network newsletter, the Neural Network newsletter is a zero-cost monthly newsletter that includes podcast summaries as well as what we call protocols in the form of one- to three-page PDFs that cover everything from how to optimize your sleep, how to optimize dopamine, deliberate cold exposure. We have a foundational fitness protocol that covers cardiovascular training and resistance training. All of that is available. It's available completely zero cost. You simply go to HubermanLab.com, go to the menu tab in the top right corner, scroll down to newsletter, and enter your email. And I should emphasize that we do not share your email with anybody. Thank you once again for joining me for today's discussion with Paul Stamets. And last but certainly not least, thank you for your interest in science.

Podcast Summary

Key Points:

  1. Paul Stamets warns that H5N1 bird flu has spread to 90 mammal species with a 40–50% human fatality rate, making COVID look minor by comparison.
  2. Fungi and mycelium possess natural immune defenses against bacteria and viruses, and these mechanisms can be leveraged to support human immunity.
  3. Fungi and animals share a common evolutionary ancestor, and mycelial networks create complex microbiomes that sustain ecosystems and host defense.
  4. Mushrooms are miniature pharmaceutical factories producing novel molecules, and roughly 200 of millions of species are known to be compatible with human digestion.
  5. Clinical trials combining Agarikon and Turkey Tail mycelium reduced vaccine adverse reactions and tripled antibody reservoirs against COVID compared to placebo.
  6. The same mycelium bundle shortened COVID symptom duration by about five days in unvaccinated patients and reduced coughing and sneezing, key transmission vectors.
  7. Psilocybin shows strong clinical promise for treatment-resistant depression, OCD, and addiction, but requires careful screening, therapeutic support, and respect for legal restrictions.
  8. Stamets argues that investing in biodiversity is an investment in biosecurity, especially as engineered bioweapons and future pandemics pose growing threats.

Summary:

In this Huberman Lab Podcast episode, host Andrew Huberman speaks with mycologist Paul Stamets about fungi, immunity, and psilocybin. Stamets opens with a stark warning: H5N1 bird flu has now jumped to 90 mammal species, and its 40–50% human fatality rate could make COVID look minor. He argues that the solution lies in "natural intelligence"—upregulating innate immunity using fungi that have evolved sophisticated defenses against bacteria and viruses over a billion years.

Stamets explains that fungi and animals share a common ancestor, and that mycelial networks create vast microbiomes that underpin ecosystems and host defense. Mushrooms act as miniature pharmaceutical factories, and his company, Host Defense, funded research showing that Agarikon and Turkey Tail mycelium grown on rice produced striking results: in double-blind, placebo-controlled trials, the combination reduced vaccine adverse reactions and tripled antibody reservoirs against COVID, while shortening symptom duration by roughly five days in sick patients.

The conversation also covers psilocybin, including clinical evidence for treatment-resistant depression, OCD, and addiction, the importance of set, setting, and therapeutic support, and the need for screening people with psychosis risk. Stamets closes by framing biodiversity as biosecurity, urging investment in natural products to prepare for future pandemics.

FAQs

H5N1 is a bird flu virus that has jumped to about 90 mammal species, and if it infects humans its fatality rate may be around 40 to 50%. Experts warn it could be more severe than COVID-19, so it deserves serious attention.

Fungi produce natural defense compounds against bacteria and viruses, and mushroom mycelium can help modulate human immunity. Research suggests certain species may boost immune readiness while also dampening harmful over-inflammation.

Mushrooms are the short-lived fruit bodies, while mycelium is the long-lived network that acts as the immune system of the fungal life cycle. Mycelium expresses far more genes and is considered more immunologically powerful for research and supplementation.

Double-blind, placebo-controlled studies found that these mycelium products reduced adverse reactions to mRNA COVID vaccines and were associated with roughly triple the antibody levels six months later. Participants took the product for only four days.

He takes Host Defense Agarikon and Turkey Tail, typically four capsules of each. He increases his regimen several days before and during periods of high public exposure, then returns to a maintenance dose.

Psilocybin remains federally illegal in the U.S., though some states and cities have decriminalized or deprioritized possession. People with a personal or family history of psychosis, schizophrenia, or bipolar disorder should avoid it or proceed only with expert screening and caution.

Chat with AI

Loading...

Pro features

Go deeper with this episode

Unlock creator-grade tools that turn any transcript into show notes and subtitle files.